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ABSTRACT 
Microfabricated Poly (ethylene glycol) Based Hydrogels for Microvascular Tissue 
Engineering Applications 
By 
Michael Paul Cuchiara 
Shortages in donor organs and the lack of therapeutic treatment options to 
address tissue loss and end-organ failure has led to intense research into tissue 
engineering based therapeutics. Cellular, tissue, and organ level therapeutics 
hold the potential to shift clinical paradigms and drastically improve healthcare 
outcomes. However, to date the only successful tissue engineering therapeutics 
have been limited to thin and avascular tissues such as skin, cartilage and the 
bladder. This is primarily due to the absence of a perfusable vasculature to 
transport nutrients and waste during in vitro tissue development and inadequate 
host-implant vascular integration upon implantation. In this thesis we set out to 
develop hydrogel microfabrication technologies to (1) improve in vitro mass 
transport, (2) integrate self-assembling microvascular networks with 
microfabricated channels and (3) incorporate and support functional parenchymal 
cellular elements within in vitro constructs. 
Application of microfabrication technologies to PEG hydrogels requires 
that fabrication schemes are cell compatible, robust for handling and imaging and 
most importantly allow for precise micron level control of both fluid perfusion and 
hydrogel structure fabrication. Herein we report multiple cell compatible 
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microfabrication schemes that employ multilayer replica molding and 
photolithographic hydrogel fabrication techniques. Systems designed with these 
techniques resulted in improved in vitro mass transport, integration of self-
assembled microvascular networks with fabricated structures and the ability to 
pattern multilayer heterogeneous hydrogel structures that contain and support 
multiple cellular elements. 
The progress reported herein has broad applicability towards the 
development of biomaterials with highly biomimetic structural-functional 
characteristics. More specifically these hydrogel microfabrication technologies 
hold the promise to improve the therapeutic potential of tissue engineered 
constructs and provide more biologically applicable pre-clinical tissue models. 
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1. Chapter 1: Need For Regenerative Medicine-Based 
Therapeutics 
Numerous pathologies exist which lead to gross tissue abnormalities, 
organ failure and require organ and or tissue transplants (see Table 1) 
Procedures associated with these pathologies place a significant financial burden 
on the health care system with more than $400 billion dollars in annual 
expenditures resulting from treatment associated with the pathology. 1 
Furthermore, of those patients seeking organ or tissue replacement most will 
perish while waiting for a transplant. For example, of the 30,000 patients who die 
from liver failure only 3,000 or 10% will receive the potentially lifesaving 
transplant. 1This trend highlights a significant shortage of donor organs and 
tissues and gives rise for a need to radically transform current clinical paradigms 
associated with transplants. 
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Table 1: Incidences of organ and tissue abnormalities and the number of 
procedures associated with the occurrence Recreated from [1] 
Indication 
2.150.000 
1.500,000 
500.000 
600.000 
200.000 
40,000 
558.200 
275,000 
480.000 
30,000 
216,000 
103.400 
250.000 
149.900 
219.300 
179,000 
14.500 
Tendon repair 33.000 
ligament repair 90.000 
Blood vessels 
Heart 754,000 
large and sman vessels 606,000 
LMIt 
Metabolic disotders 5,000 
liver ointtosia 176.000 
LMIt cancer 25,000 
Pancreas (diabetes) 728,000 
Intestine 100.000 
I<idney 600,000 
Bladder 67.200 
Uret8r3O.OOO 
Urethra 51.900 
Hernia 290,000 
Brea&t 261,000 
Blood transfusiof'I$ 18,000,000 
Dental 10.000,000 
.~ 150,000 of theSe individuals are he)&. 
pitaIINd and 10.000 die 8f'II'1U$IIy. 
The 10% of the tissues or organs that are transplanted can be divided into 
two categories either autologous or non-autolgous sources. Autologous sources 
refer to procedures which harvest tissue from healthy regions in the patient's 
body and transplant these tissues to the site of pathology in order to augment or 
replace the abnormally functioning tissue. For example, the sapehnous vein is 
used in vascular bypass surgery 2 to provide a patent vessel for blood flow while 
the hamstring tendon is often harvested to replace or augment the mechanical 
functions of injured ligaments in the knee joint3. Autologous transplant strategies 
offer complete biocompatibility and often help to restore a large amount of 
function to the diseased tissue. Unfortunately, autologous transplants result in 
loss of function at the site of tissue harvesting a side effect known as donor site 
morbidity. Furthermore, the need for multiple tissue transplant procedures may 
deplete the donor site supply to such an extent that the originally normal tissue 
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function at the donor site may be permanently damaged. Non-autologous 
sources such those produced form human cadavers (allografts) and from other 
species (xenografts), are not limited by donor site morbidity but these tissue 
transplants have a greatly increased risk of disease transmission, have poor 
biocompatibility, often illicit a strong immune response and require that the 
patient remain on immunosuppression therapy for the remainder of their lifetime. 
4,5 
Thus there exists a need to develop tissue engineering based strategies to 
augment and or replace the current clinically accepted strategies surrounding 
organ and tissue transplantation. Tissue engineered therapeutics circumvent the 
need for large scale tissue harvesting from donor tissue by providing ex vivo 
culture conditions to develop the engineered tissue into clinically viable 
constructs. Tissue engineering effectively minimizes if not eliminates donor site 
morbidity and coupled with the proper choice of materials, tissue engineering 
holds the promise to greatly reduce the biocompatibility and disease 
transmissions concerns surrounding non-autologous transplantation procedures. 
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2. Chapter 2: Tissue Engineering Strategies 
A common paradigm has emerged to integrate diverse disciplines, and 
mimic the in vivo characteristics of tissue organization and content. (Figure 1) 
This paradigm consists of three general branches: the recapitulation of a 
provisional extracellular matrix analog or scaffold; incorporation of bioactive 
signaling factors and the presence of cellular or multicellular components. Proper 
integration of all branches is necessary to facilitate the production of tissue 
engineering therapeutics with successful clinical outcomes. 
Signal 
Cells Scaffold 
Figure 1: Tissue Engineering Paradigm. Combination of cells, bioactive signals, and 
scaffolding components to mimic in vivo tissues has governed tissue engineering system design 
throughout its first 20 years. 
Comprehensive analysis of the scientific literature surrounding tissue 
engineering yields important design considerations and useful engineering 
parameters for recapitulating these environments. However, the highly complex 
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and dynamic nature of cellular, biophysical, and biochemical enactors makes 
highlighting the sufficient and necessary signals in tissue development a 
daunting task. None the less, it is important to develop an overarching strategy 
that includes a synergy of cellular constituents, matrix or insoluble components, 
and soluble signals together to drive tissue formation. 
Selection of the proper cellular elements is integral in providing the correct 
phenotypical cellular activity as well as the functional aspect of the tissue. Cell 
sources must also account for the heterogeneous nature of complex tissues and 
often require multiple cell types to be seeded within the construct. Another 
approach that has recently gained interest is the use of pluripotent cell types to 
provide all of the cellular components of the construct. This is advantageous 
because it does not require multiple cell sources the seeding of multiple cell 
types. 
Soluble signals in the form of nutrients and signaling factors are crucial to 
determining cell phenotype, morphology and to spatially direct tissue formation. It 
is not only important to determine the type and concentration of bioactive factor 
but it is critical that the factors be dynamically presented in the system. 
Furthermore spatial presentation of the factors has an important effect on tissue 
formation. Soluble factors whether as a product of media components, cell 
secreted signals or released from the matrix must be carefully controlled and 
characterized in order to direct tissue development. 
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The extracellular matrix (ECM) plays multiple important roles in providing 
physical scaffolding, sequestering soluble growth factors, and establishing 
hapotactic signaling gradients for cell adhesion and migration. Furthermore, the 
ability of the ECM to remodel and react dynamically to the environment is a 
crucial characteristic in regulating cell migration and tissue formation behaviors. 
Therefore when designing vasculogenic ECM biomimetic systems the researcher 
needs to provide a matrix substitute that provides a dynamic multifaceted 
interaction with the cellular elements. Although it is important to determine the 
optimal combination of cells, signals and ECM components, much of our 
research focuses on development of scaffolds to mimic the ECM. 
2.1. Scaffolding Strategies 
Tissue engineering scaffolds seek to mimic the native ECM by providing a 
physical architecture as well as a source of biochemical signals to support 
cellular adhesion, migration, morphology, and tissue formation. Biomimetic ECM 
scaffolds can be loosely categorized as either natural or synthetic based 
materials, with some constructs incorporating a combination of both6. Natural 
materials that are commonly used for microvascular tissue engineering are 
collagen7, agarose8, alginate 9, and fibrin 10 matrices. The use of natural materials 
as scaffolding constructs is advantageous due to their inherent bioactivity and 
biodegradation, which allows for cell-ECM signaling and tissue remodeling with 
minimal modification of the material. However, the ability to independently tailor 
the physical and biochemical properties of the material is difficult. Thus 
identifying and decoupling important physical and biochemical enactors is 
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prohibitive in natural systems. Furthermore, batch to batch variability and the risk 
of disease transmission and adverse host immune reactions in natural 
scaffolding materials makes implementing good manufacturing practices difficult 
and has discouraged the clinical application of these materials due to regulatory 
concerns. Despite these drawbacks, natural materials are commonly employed 
as MVTE scaffolds and at the very least provide a template for synthetic 
materials to mimic. 
Synthetic scaffolds provide a greater degree of control over scaffold 
physical and biochemical properties. Unlike natural materials synthetic scaffolds 
have little or no risk of disease transmission with manageable immunogenicity 
and cytotoxicity. 11 Batch to batch variability can be reduced through proper 
quality control measures and common characterization techniques. However, in 
order to mimic the ECM, most synthetic scaffolds require the incorporation of 
bioactivity into inherently non-biomimetic systems. Modification of synthetic 
scaffolding materials with various ECM proteins is a common mechanism to 
precisely engineer bioactive signaling components of tissue engineering 
scaffolds. Proteins such as fibronectin, fibrin, agarose, gelatin, and collagen have 
been used to coat or impregnate the matrix of synthetic polymers such as 
poly(dimethyl siloxane) (PDMS), poly(caprolactone), poly(tetrafluoroethylene) 
(ePTFE), and Dacron. 12 
Independent of material type, the manner in which the scaffold is 
fabricated has a great affect on construct physical properties. A wide variety of 
scaffold fabrication techniques have been developed to alter scaffold bulk 
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properties in order to improve mass transport and cellular migration 
characteristics. Particulate leaching 13, polymer phase separation 14, gas foaming 15 
and electrospinning 16 have all been shown to increase average pore size, 
facilitate pore interconnectivity, and enhance overall porosity at the nano- and 
micro-scale.(Figure 2) Optimal macroporous architectures should allow for tissue 
ingrowth and cellular migration without compromising desired scaffold 
mechanical properties. Examples of scaffolds with average pore diameters 
ranging from 10-100 IJm have been shown to facilitate cellular ingrowth and 
migration. 13-16 (Figure 2) Furthermore, selection of optimal pore geometries and 
average pore diameter should reflect the native tissue type of interests and be 
carefully integrated with cell seeding methods and overall construct integration 
schemes. 
Although these techniques have been shown to improve bulk mass 
transport properties, they provide little or no spatial control over fabricated 
microarchitectures. Furthermore, cytotoxic processing conditions require cell 
seeding to occur post scaffold processing. This methodology often results in non-
homogenous cellular distribution throughout the thickness of the scaffold and 
limits the overall metabolic density of the construct17-19. Next generation 
fabrication technologies should provide the ability to spatially tailor scaffold 
architectures so as to control cell migration and tissue formation. 
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Figure 2: Scaffold Processing and Fabrication Techniques. Techniques allow for bulk 
tailoring of physical architecture. However current techniques are not cytocompatible and have no 
ability to spatial control architecture. Recreated from Mooney et at?, Ma et al.48 and Harris et al.49 
One class of synthetic materials which shows great promise as tissue 
engineering scaffolds is hydrogels. Hydrogels have favorable scaffolding 
properties and closely mimic in vivo systems due to their high water content and 
tissue-like elastic properties. Furthermore, the large interstitial aqueous fraction 
of hydrogel systems facilitates rapid water soluble mass transport. 20 This 
property coupled with the fact that tissue engineering hydrogel systems are often 
less than 10% polymer fraction by mass, permits a greatly reduced effective 
diffusivity and improved mass transport when compared to non-hydrogel polymer 
scaffolds. 21 Multiple hydrophilic synthetic polymers have been used to generate 
18 
hydrogel systems for tissue engineering including, poly(ethylene glycol) (PEG), 
poly(hydroxyethyl methacrylate) (PHEMA), poly(vinyl alcohol) (PVA) , poly(acrylic 
acid) (PAA) , poly(methacrylic acid) PMMA, and poly(acrylimide) (PAAm).21 
Perhaps the most widely studied hydrogels system for tissue engineering 
applications are PEG-based scaffolds. PEG hydrogels are non-toxic, non-
immunogenic, and approved by the US Food and Drug Administration for a 
variety of clinical applications. 21 Furthermore, PEG has been touted as a "stealth" 
material due to its ability to resist protein adsorption and evade adverse foreign 
body immune reactions. 22 In addition, PEG's intrinsically low protein adsorption 
provides a blank slate to specifically engineer the desired scaffold bioactivity 
while maintaining independent control over system physical properties.23.24 For 
these reasons the remainder of microvascular scaffolding design discussions will 
focus on the fabrication and modification PEG hydrogel based systems. 
2.1.1. PEG Hydrogel Crosslinking Techniques 
Crosslinked PEG hydrogel scaffolds possess many important biomimetic 
properties of the extracellular matrix including high biocompatibility. This has led 
to intense interest in PEG-based materials as scaffolds for tissue engineering 
and regenerative medicine applications. However, independent of the scaffold, it 
is important that the conditions used to crosslink PEG pre-polymer solutions are 
compatible with cellular components. This is critical if cells are to be 
encapsulated and/or if the scaffold is to be used as an in situ gelling construct. 
Free-radical based polymerization of acrylate terminated PEG macromers and 
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Michel-Type addition reactions between free thiols and acrylate groups have 
become the most prevalent means for crosslinking PEG scaffolds. 
Michael-Type addition reactions were first reported by Hubbell's research 
group in the late 1990's as a means for crosslinking bioactive PEG scaffolds. 25 
Michael-Type crosslinking mechanisms are base-catalyzed addition of free- thiols 
to acrylates in a one-to-one additive fashion. (Figure 3A) The process is 
cytocompatible and relatively rapid, proceeding to completion in 30 min at 37 DC 
and a pH of 7.4. 26 Michel-Type hydrogels are degradable through hydrolysis 
without the need to engineering specific degradable co-polymers. 27 Another 
advantage of Michel-Type PEG hydrogels is that the thiol side chain on the 
cysteine amino acid can be systematically used as a biocompatible crosslinker 
and as a means to immobilize proteins and oligopeptide sequences in the 
scaffold.28 Cell encapsulation within Michel-Type hydrogels at neutral pH and 37 
DC often exhibit non-homogenous cell dispexing devicesrsion due to gravity 
driven cell settling during the slow gelation time.The use of mi to disperse cells 
during crosslinking or elevated pH and and/or temperatures improves cellular 
dispersion. Also the use of mutli-armed thiol or acrylate terminated crosslinkers 
increases the rate of gelation and provides a mechanism to improve gel 
mechanical properties.29 
The other dominate mechanism to drive PEG hydrogel gelation is free-
radical based chain elongation from acrylate terminated PEG macromers. This 
process is very rapid and takes advantage of hydrophobic-driven self-assembled 
acrylate micelles that co-localize prior to free-radical addition and promote rapid 
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crosslin king. Furthermore, a single free radical will add in a chain elongation 
mechanism crosslinking many PEG pre-polymer chains from a single radical and 
creating polymerization nodes or crosslink centers. 30 In this respect free-radical 
crosslinked PEG hydrogels form much faster « 1min2o vs 30 min26) and much 
stiffer (5000 Pa31 vs 300 Pa26) matrices than Michel-Type at a given hydrogel 
concentration and PEG pre-polymer molecular weight. It should also be noted 
that free-radical crosslinked PEG hydrogels are not degradable by cellular 
proteases or hydrolysis at physical pH or temperature. Therefore it is necessary 
to design hydrolytically or proteolytically degradable co-polymers. 
The mechanism of how a free -radical is generated greatly affects the 
utility and application of free-radical crosslinked PEG hydrogels. The well 
characterized free-radical initiator system of ammonium perfsulfate (APS) and N, 
N, N', N'-tetramethylethylenediamine (TEMED) is commonly used to generate 
free radicals and drive hydrogel crosslinking. 32 However the temperature to drive 
rapid initiation (> 50 DC) and both components, APS and TEMED, have been 
shown to be cytotoxic and significantly reduce the applicability of these systems 
for cell encapsulation and in situ gelling applications. 
More recently photopolyemrizable techniques have been applied to 
crosslink PEG hydrogel scaffolds.2o These systems use the combination of light 
and a photoiniator as a free radical generator to initiate the chain elongation 
process. (Figure 38) A wide variety of photoinitiators that react to various 
wavelengths of light have been shown to promote rapid photopolymerization with 
low cytotoxicity.33 Furthermore these systems allow for sub-micron scale 
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photolithographic spatial patterning of structures34, biochemical35 and biophysical 
functionalities36 within the scaffold. This has proven advantageous for 
investigating fundamental cellular phenomena and for fabricating tissue mimetic 
microenvironments. (see section 64 Microfabricated Hydrogels for MVTE) 
A X ~ Xx + )00( -/' 
MallHnD Dilltlol 
PEG A 
(a) (b) 
I .... IN-..rk 
Figure 3: PEG Biofunctionalization and Crosslinking Systems. (A) Michel-Type PEG 
crosslinking27 and (8) free radical photopolymerization based PEG crosslinking37 
2.1.2. Techniques for PEG Scaffold Biofunctionalization 
Often PEG materials are used to improve surface wet-ability, prevent 
protein adsorption, improve biocompatibility, and create "stealthy" biological 
interfaces. These are advantageous qualities when designing inert interfaces or 
improving biodistribution. However, for tissue engineering scaffold-based 
applications, PEG's intrinsically bioinert properties require the incorporation of 
bioactivity to communicate with biological and cellular environments. 
Generally, biofunctionalization of PEG based scaffolds can be achieved 
via impregnating or non-covalently loading biomolecules into the matrix38,39 or 
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through covalently crosslinking biomolecules into the matrix40-42 and 
combinations of both43. Non-covalently loading biomolecules into the scaffold is 
simple and does not require development of specific chemical modification 
schemes to drive functionalization . This method also allows for biomolecule 
release from the scaffold resulting in the formation of chemotractant gradients 
originating from the scaffold surface and extending into the tissue space.44 
(Figure 4 A&B) This may be advantageous for facilitating native tissue ingrowth 
and cell infiltration. In particular this is a useful tool for MVTE because it may 
provide a means to recruit existing blood vessels into the scaffold and therefore 
improve anastomosis times.43 (Figure 4C) 
A 
Drug dis olved in hydrogel 
) 
B . . 
hydrogel . . . 
Time 0 Timet 
Figure 4: Soluble Bioactive Factor Release from Hydrogel Scaffolds. Soluble factor release 
from non-degradable hydrogels (A) and degradable hydrogels. The release from non-degradable 
hydrogels is not dynamic and concentration and diffusivity dependent. The release profile. from 
degradable hydrogels ins dynamic and will vary as a function of the mechanism of hydrogel 
degradation. (C) VEGF release from hydrogel scaffolds induces blood vessel growth up the 
concentration gradient in the surrounding tissue. Recreated from Peppas et al.21 and Zisch et al.28 
However, the bioactivity of non-covalently loaded biomolecules decreases 
over time when compared to covalently tethered biomolecule. This is due to 
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reduced biomolecule concentration through both diffusional release from the 
scaffold (Figure 4) and cellular internalization followed by breakdown via 
intercellular enzymatic pathways.28 Consequently, much effort has focused on 
ways to covalently immobilize biomolecules to PEG hydrogels without disrupting 
native bioactivity. Commonly biomolecules are immobilized through 
heterobifunctional conjugation to primary amine terminus45 or amino acids with 
free side chain amines (lysine)46 through n-hydroxysuccinimide reactions(Figure 
5), carbodiimide coupling, or other amine reactive chemistries.47 Amino acids 
with free thiols (cystine)48 have also been commonly used as the reactive sites 
for biomolecule conjugation to PEG scaffolds especially when Michel-Type 
crosslinking is employed. 
Targeting native free amine or free thiol rich residues on biomolecules 
allows for easy bioconjugate production without the need for engineering specific 
conjugation domains.(Figure 5) However, close spatial localization of the 
conjugation site to either tertiary structure stabilizing regions (ie. disulfide bonds) 
or cellular binding sites has shown to reduce bioconjugate activity.49 It is possible 
to avoid this drawback by optimizing the molar ratio of conjugation linker to 
reactive site, carefully choosing biomolecules with stable conjugation sites,42 or 
by designing protein and oligopeptide sequences with specific conjugation sites 
through either synthetic peptide synthesis50 or recombinant protein expression. 51 
Optimization of reaction conditions commonly allows for immobilization that 
preserves biomolecule acitivity52 as shown through bioconjugate bioactivity 
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assays used to evaluate conjugation effects and determine optimal dosage 
concentrations that produce desired scaffold biomimetic behavior. 
A 
B 
prtHem w~th $C¥t'rn~ 
Jh::c amine gn~up$ 
o f >- 0 0 ~·~·-<I,J - ~.~~ 
.-\qylayf, PfO-NHS 11 A ~ottir. widl QfW iti::J[t;Jtc (.:.m be 
);:'l(."tUPUT.U,oo mfa ph(ttoroJYUlCtilCd 
hrdrogds !L~ pcnd;mt cb.&ms 
Figure 5: Effects of Multiple Heterobifunctional PEG-Biomolecule Conjugation Sites. (A) 
Biomolecules with only one free primary amine to react with acryoyl-PEG-N-hydroxysuccinimide 
act as tethered biomolecules with little steric hindrance and reduced conjugation site effects on 
bioactivity. (8) Biomolecules with multiple free primary amines to react with acryoyl-PEG-N-
hydroxysuccinimide act as crosslin king reagents with sterically reduced access and potential for 
negative conjugation site effects on bioactivity. Recreated from Miller and Wese7 
Independent of conjugation site effects, it has also been shown that direct 
covalent immobilization of biomolecules can result in decreased bioactivity due to 
steric hindrance of cell reactive domains. 53 The use of bioinert spacers has been 
shown to improve steric hindrance and provides a means to tether biomolecules 
into the PEG hydrogel matrix. As an example our group has shown that the use 
of a heterobiofunctional PEG spacer, with an amine reactive n-
hydroxysuccinimide and an acrylate terminated end group can provide a robust 
method to covalently anchor biomolecules to the scaffold with minimal affects on 
bioactivity and greatly reduced streric restrictions. 23 (Figure 6) 
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Figure 6: Heterobifunctional Biomolecule Conjugation Schematic. (A) 8iomolecule 
conjugation using a heterobifunctional acrylate-N-hydroxysuccinimide moiety (A) without a PEG 
spacer and (8) with a PEG spacer. Recreated from Hem and Hubbell23 
The use of heterobifunctional acrylate-PEG-Biomolecule moieties is 
compatible with cellular encapsulation using either Michel-Type54 or free radical 
driven techniques55 and allows for specific bioadhesion45 , control over tissue 
formation56, and cell migration through proteoltyic degredation57. A very 
interesting recent finding in acrylate-based hydrogel systems demonstrates that 
that increasing concentrations of monoacrylated PEG derivatives surprisingly 
enhances the free radical based PEG crosslinking process. This finding 
emphasizes the importance of thermodynamically stabilizing the hydrophobic 
acrylate micelle on scaffold crosslinking properties. (Figure 7)and enables the 
development of PEG scaffolds systems with increasing amounts of bioactivity 
and biomimetic components without compromising scaffold physical properties. 30 
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Figure 7: Schematic Representation of Photopolymerized PEGDA Network Formation. (a) 
PEGDA crosslink, (b) un-reacted acrylate, (c) cyclic crosslinks, (d) chain entanglements and (e) 
PEG tethered biological moiety. Reproduced from Beamish et a.i30 
2.2. Current Success and Challenges in Tissue Engineering 
Therapeutics 
The concept of directly engineering tissues for the development of 
therapeutics which seek to substitute, restore, maintain and or improve tissue 
function was born in the late 1980's and began to take root with the publishing of 
a ground breaking article in a 1993 issue of Science by Robert Langer and 
Joseph Vacanti's aptly titled Tissue Engineering. Since then the field has 
experienced significant growth with annual industrial and scientific research and 
development expenditures totaling $600M in 2001. 58 However, to date the only 
successful tissue engineering therapeutics have been limited to those seeking to 
augment skin, cartilage or the bladder. 59,60 The chief reason theses tissues have 
been successfully engineered is due to either their intrinsically low metabolic 
activity and or the constructs are sufficiently thin to allow nutrient and waste 
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transport to occur by either host vasculature integration or by purely diffusional 
process. Implanted tissues with greater thicknesses and metabolic consumption 
rates require that the host vasculature provide nutrient transport. However, 
vessel in growth occurs on the order to tens of micrometers per day61 which 
would require weeks to months in order to vascularize constructs on the order of 
millimeters to centimeters. During this time hypoxic conditions followed by 
cellular necrosis will occur in regions furthest from the implant surface. 
Furthermore, heterogeneous nutrient and waste concentration gradients across 
cellular layers of the implant will lead to non-uniform cellular differentiation and 
behavior ultimately leading to a reduction in therapeutic potential. 62 Such mass 
transfer properties dictate that implanted tissue engineering therapeutics without 
perfused vasculature are limited to thicknesses on the order of 150-200 um.63,64 
In order to develop bulkier more complex tissues with high metabolic 
activity such as heart, lung, liver, muscle, or neural tissue it is necessary to 
provide tissue engineering constructs that are vascularized pre-vascularized in 
vitro prior to implantation. Pre-vascularized constructs with perfused 
microvascular networks improve nutrient and waste transport by providing mass 
transport in the form of vessel supported convection followed by extra vessel 
diffusion. Appropriate vessel design parameters such as microvascular network 
geometry, density, and perfusion rates can provide fundamental design 
parameters that limit cellular necrosis in vitro by controlling the number of cell 
layers between perfused vessel networks. More importantly, perfusable 
microvascular networks within the pre-vascularized implant will allow for both 
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microvascular surgical connection to the implant and reduce the effective 
distance of host vessel in-growth to the surface of the implant. It is important then 
to take a step back and study the biology and physiology of how tissues are 
vascularized. 
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3. Chapter 3: Vascularization of Tissues 
3.1. Microvascular Physical Characteristics and Function 
Blood vessel networks or the systemic vasculature functions to deliver 
nutrients and remove metabolic waste products from tissue. These networks can 
be generally classified into three groups; the arterial circuit, the capillary networks 
or microvasculature, and the venous circulation. Each network component has 
diverse cellular and extracellular matrix (ECM) compositions as well as physical 
characteristics that reflect their unique biological functionality. 
Figure 8: Circulatory System 
with emphasis on Microvascular 
Component. (A)The circulatory 
system composed of the arterial 
and venous circuit bridged by 
capillary bed. (8) Microvascular 
networks depicting regular 
branching. (C) Cherry stain of 
skeletal muscle vasculature. (D) 
Schematic of vasculature (red), 
pericytes (green), and basement 
membrane (blue). 
Derived from Jain et al. 182 
The arterial network provides pressurized delivery of oxygenated blood 
from the heart to the tissue. The venous system returns deoxygenated blood 
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passively from the peripheral circulation back into the central circulation and 
ultimately back to the heart. Both function primarily as highly dispersed, large 
diameter, convective based transport vessels with little to no exchange of solutes 
across the vessel into the tissue space. Connecting the two networks are 
intricate, ultra high surface area, capillary beds. These microvessels are small in 
diameter commonly consisting of two to three endothelial cells in diameter. 
(Figure 8) 
The EC networks found within the microvasculature are surrounded by a 
laminin and collagen rich basement membrane reinforced by a single layer of 
pericytes. 65 The thin basement membrane, lack of confluent pericyte presence, 
inherently leaky EC cell-cell contacts coupled with the high surface area of 
capillary networks provides a highly permeable element of the circulatory system 
where exchange of nutrients and waste from the tissue space can occur freely. 
(Figure 9) Much of the following discussion will focus on the rationale design of 
systems which seek to mimic the function of the microvasculature within in vitro 
systems. 
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Figure 9: Composition of Blood Vessels. (a) Early EC tubes mature into (b) capillary structures 
containing an EC tube surrounded by the matrix rich basement membrane and sparse vessel 
stabalizign pericutes.As percicte coverage thickens pericytes begin to differentiate into smooth 
muscle cells capillaries form arterioles and venules (c). The walls of the largest vessels (d) are 
divided into three distinct layers the intima, media and adventitia. Mature vessels also contain 
their own blood supply, vaso vasorum, to support cellular nutrient demands. Recreated from Jain 
et al.66 
3.2. The Developing Microvasculature: Vasculogenesis 
The formation of blood vessels is thought to occur in multiple distinct 
morphogenic processes. Vasculogenesis is thought to primarily occur in a 
prenatal environment during embryo development and in the most general of 
terms refers to the de novo formation of vascular networks from mesodermal 
progenitors. In contrast postnatal vessel development occurs when EC are 
activated, such as during wound healing, hypoxia, and metastasis. Postnatal 
vessel development refers to the formation of a new sprout from an existing 
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vessel (angiogenesis) or the bifurcation of a larger diameter parent vessel into 
two smaller diameter daughter vessels (intussusceptions). Recently, evidence 
has arisen that suggests during times of tissue repair circulating multipotent stem 
cells or endothelial cell precursors (EPC) in the circulatory system contribute to 
vessel formation in a process that resembles lymphoid lineage homing combined 
with embryonic vasculogenesis. 67 Although post- and pre-natal vessel 
development are governed by unique signaling events, together they provide key 
rational design information and parameters utilized in the development of 
microvascular networks in vitro. 
Vasculogenesis occurs in the embryo when mesodermal progenitors 
begin to differentiate into EC precursors. This specialization is marked by the 
coalescence of progenitors into structures referred to as blood islands. The 
fusion of adjacent blood islands results in the formation of primitive tube like 
networks known as the capillary plexus. 65 (Figure 10) Branching and remodeling 
of the plexus leads to the development of a mature vessel network while the 
initiation of blood flow is thought to further develop the network and drive the 
hierarchical organization into larger diameter venules and arterioles. 68 
Molecular regulation of initial plexus formation is thought to be governed 
by both soluble and insoluble factors provided within the local microenvironment. 
Fibroblast growth factor (FGF) 14, vascular endothelial growth factor A (VEGF-
A)69, Indian hedgehog (lhh)7o, and Quaker71 signaling have all been implicated in 
the differentiation of mesodermal progenitors to the EC phenotype found in the 
primary capillary plexus. Proper transient expression profiles of these soluble 
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factors and their target receptors provides the regulation necessary to not only 
promote the initial EC cell phenotype from progenitors, but also balance physical 
network characteristics such as network density and tubule diameter. 
Vasculo,enesiS 
, Fusion 
Primary capillary 
plexus 
EC Lineage Commitment and Different iat ion 
bFGF 
• 
(FGFR) VEGF-A 
• ~ .. 
Mesoderm Flk-l, Flt-1) 
Blood Vessel 
Assembly 
1 /. EC Recruitmen.t of Mural Cell Progenitors Primord ial ~ Endothelium 
........ Cell-cell communication 
... (Tie-2) Cell-matrix Interactions 
Adult 
Stem Cells ~/ 
~f 
(PDGFRll) 
Mesenchyme 
Activation Upregulatlon 
of TGF-~ -+ of SRF 
______ TGF-f\. 
SRF 
SMClPeric te Differentiation 
Figure 10: Schematic of Vasculogenesis. (left) Coalescence of EC precursors into blood 
islands and subsequent organization in the primary capillary plexus. (right) EC lineage and 
differentiation with role of signaling factors and mural cell progenitors. Recreated from Hirschi et 
al. 13 and Jain et al. 16 
The driving force behind the formation of the primary capillary plexus with 
distinct vessel lumens from blood islands is thought to be governed in part by 
intercellular vacuole fusion.72 Recent in vivo studies in zebrafish and in vitro 
studies of human EC on collagen gels indicate that longitudinal intracellular 
vacuole compartments fuse to form intracellular lumens. 73 (Figure 11) 
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Figure 11 :Vacuole Fusion Precedes Lumen Formation. (A) HUVEC on collagen gels fuse 
vacuoles to form lumens. (8) Zebra fish dorsa aorta vessel outgrowth via vesicular fusion . (C) 
Mechanism for lumen formation. Reproduced from Kamei et al. 73 
Development of the primary plexus into mature capillary beds is thought to 
be partly controlled through EC interaction with mural cells or pericytes. 
Recruited pericytes regulate vessel blood flow via contractile forces and also 
function to stabilize the nascent endothelial vessel via both physical interactions 
and signaling cascades that promote EC viability and suppress EC proliferation. 74 
Endothelial cells attract pericytes from the mesoderm chiefly via the secretion of 
platelet derived growth factor-beta (PDGF-~). Furthermore, PDGF-~ is known to 
be a powerful mitogen and chemotractant and is thought to be responsible for the 
differentiation of pericytes down the smooth muscle cell (SMC) lineage. 75 Upon 
EC-pericyte contact, transforming growth factor beta (TGF-~) is thought to 
become activated due to the heterocellular receptor interactions. Activated TGF-
~ directly up regulates gene expression of SMC marker SM-a-actin and indirectly 
up regulates other SMC markers, SM-y-actin, SM22-actin, and calponin through 
activation of serum response factor (SRF). 65 These soluble effectors present in 
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the capillary microenvironment are crucial to developing stable microvascular 
networks in vitro. 
3.3. The Dynamic Microvasculature: Angiogensis 
As previously described, postnatal vessel development is thought to occur 
via angiogenesis or the sprouting of new vessels from existing vessel networks. 
Also there are non-angiogenic mechanisms in postnatal vessel development 
such as intussusceptions or the bifurcation of a parent vessel into two smaller 
diameter daughter vessels, and the spontaneous formation of vessels form 
circulating multipotent stem cells. Although the contribution of non-angiogenic 
neovessel formation is thought to be minor68, each mechanism involves unique 
chemotaxic, haptotaxic and cell mediated signaling events which provide 
important rational design considerations for in vitro microvascular tissue 
engineering strategies. 
Perhaps the most widely recognized and dominant mechanism of 
postnatal neovessel formation is the sprouting of vessels from existing 
vasculature or angiogenesis. This process involves the selection/activation of 
endothelial cells known as "tip cells" via Notch-Delta like 4 ligand (DLL4) cell-cell 
contacts. These cells undergo a drastic change in phenotype from quiescent 
behavior to highly invasive and migratory activity with up regulation of both 
soluble and membrane bound proteases in addition to apical basal polarity 
changes. Local degradation of the basement membrane by the tip cells is 
thought to release pro-quiescent factors to adjacent ECs while local 
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concentration gradients of VEGF-A either through the release of the matrix 
bound isoform (VEGF 165) or as soluble enactor (VEGF 121) is thought to 
spatially direct and encourage sprout elongation. 76 Stabilization of the growing 
sprout is thought to occur by the recruitment of pericytes through secretion of 
PDGF-~ by the sprouting EC.68 The nascent sprout is thought to continue growth 
until the "tip cell" encounters another "tip cell" or an existing capillary where 
stable cell-cell contacts must occur. Subsequent lumen formation is necessary to 
encourage blood flow and perfusion. There is a growing body of evidence to 
suggest that vessel lumen formation is closely tied to pinocytosis and or vacuole 
formation. Where polarity of the lumen is established by integrin-matrix contacts 
and fusion of vesicles precedes polar exocytosis and subsequent lumen 
formation. 77 (Figure 12) It is also thought that lumen formation occurs co-
currently with sprout elongation. 
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Figure 12: Sprouting Mechanism of Angiogenesis. (a) Initial change of EC polarity and 
expression of invasive phenotype. (b) Sprout outgrowth and degradation of ECM. (c) Proliferation 
of sprout cells and pre-lumen vacuole formation. (d) Perfusion of neo-vessel and stabilization by 
PC contact and ECM synthesis. Recreated from Adams et al.68 
The contribution of non-angiogenic neovessel formation provides insight 
into additional mechanisms which promote neo vessel formation. Circulating 
endothelial precursor cells (EPC) have been implicated in the formation of the 
sprout themselves and also function to signal existing EC to begin the sprouting 
process.78 Intussusception is the most poorly characterized mechanism of vessel 
formation. (Figure 13) This process involves the excessive proliferation of EC, 
degradation of basement membrane matrix and polarity changes which lead to 
the formation of a tissue pillar or bifurcation site. It is reasonable to assume that 
the pinocytotic and the vacuole based lumen mechanism may function along with 
the tissue pillar generation to develop the bifurcation site. 
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Figure 13: Non-Angiogenic Mechanisms of Postnatal Vessel Formation. (a) Circulating cells 
initiate sprout formation by adhering and displaying invasive phenotype. (b) Insertion of a tissue 
pillar by excess secretion of matrix by EC. Recreated from Adams et al. 68 
3.4. Microvascular Tissue Bed Mass Transport 
The most important function of the microvasculature is the ability to 
transport molecules from the circulation into the interstitial tissue space. This 
critical mass transfer functionality is supported by an ultra high surface area of 
500-700 m2 in adult humans and high vessel density where on average no 
functional cell is greater than 30 um from a capillary79. Furthermore the capillary 
walls are extremely thin tubular structures often containing only one cell layer 
surrounded by a basement membrane with a total thickness of 500 nm. Together 
these characteristics provide favorable physical system for the efficient exchange 
of nutrients in a tissue bed. 
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The mechanism of molecular transport out of the vessel lumen into the 
interstitial space is highly dependent upon the molecule of interest. Small lipid 
soluble molecules such as oxygen and carbon dioxide can diffuse directly across 
the capillary endothelium and therefore move at a much higher rate than other 
solutes.79 Small molecules that are water soluble but lipid insoluble cannot pass 
through the cell membrane but instead rely on interendothelial cell clefts as 
passageways out of the microcirculation. Molecules such as water and glucose 
and electrolytes such as sodium and potassium ions are thought to rely on this 
mechanism for transport. 79 
Macromolecular microvascular transport is less understood and there a 
multiple theories proposing transport mechanisms. Larger molecules, such as the 
plasma protein albumin (MW = 67 kDa, radius = 3.55 nm), have molecular radii 
that approach size of intercellular clefts (6-7 nm). Therefore molecules on this 
size order experience both significant hydrodynamic drag and steric hindrance 
within the clefts resulting in a decrease in vascular permeability with an increase 
in molecular size. However, increases in molecular weight beyond albumin result 
in only a modest decrease in permeability that is not consistent with purely 
intercellular cleft based transport. This suggests a mechanism of transport other 
than the small intercellular clefts or pores. Rippe and Haraldsson proposed a two 
pore theory suggesting that there was a second, larger diameter, population of 
intercellular clefts responsible for the enhanced transport of larger diameter 
macromolecules. 8o Still others have proposed that macromolecules can be 
transported across the microvascular endothelium via a traditional vesicle 
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supported transcytosis pathway. This process can occur through passive 
endocytosis or for common serum proteins such as albumin through active 
receptor mediated endocytosis. 81 Still other research proposed that 
macromolecular transport is a combination of both transcytotic vesicular transport 
and fusion of vesicles to form a trans-endothelial pathway.82 (Figure 14) The 
broad range of proposed mechanisms present in the literature for over 100 years 
still requires more in depth fundamental biology studies to identify key 
mechanistic trends across tissue types and to develop an integrated paradigm of 
microvasculature structure and function relationships. Several comprehensive 
reviews by Michel and colleagues82-84 provide an in depth look at microvascular 
permeabilities that is beyond the scope of this discussion. 
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Figure 14: Schematic of Microvascular Mass Transport Pathways. Multiple mechanisms 
likely contribute to macromolecular mass transport across capillary endothelium. The transcytotic 
pathway contribute via passive or receptor mediated vesicular fusion (left). In some cases 
transcytotic pathways can fuse to form a trans-endothelial pathway (right). Transport between 
endothelial junctions or in the some cases the larger fenestration also contribute to mass 
transport (center). [83] 
Given the heterogeneity of tissue function, and the parenchymal and 
microvasculature architectures that support this function, it is likely that an 
amorphous fusion of all macromolecular transport process occur to a greater or 
lesser degree depending on the needs of the tissue of interest. It is therefore 
important to consider the heterogeneity of microvascular permeabilities across 
tissue types. For example, liver capillary membranes are very porous to all 
solutes freely allowing passage of plasma proteins while the renal glomerular 
membranes is highly permeable to electrolytes and water but is selectively 
impermeable to plasma proteins. 79 This heterogeneity is an example of a strong 
structure-function transport relationship that likely dictates the type and level of 
transport mechanism present for a given tissue type. Vascularized tissue 
development in vitro must carefully consider design parameters to drive specific 
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microvascular formation directly related to the tissue type of interest. Cellular 
elements, provisional scaffold properties, soluble signals and hydraulic perfusion 
regimes must be carefully selected and tailored for the given tissue type in order 
to ensure proper tissue structure and function. 
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4. Chapter 4: Microvascular Tissue Engineering (MVTE) 
4.1. Role of Vascularization in Improved Tissue Engineering Therapeutics 
Development of robust, in vivo-like tissues in vitro holds the potential to 
create regenerative medicine therapeutics, provide more physiologically 
significant pre-clinical models and supply a pharmacological and toxicological 
screening platform that reflects in vivo systems in both complexity and function. 
Despite Significant progress, tissue engineering research has largely failed to 
produce tissue or organ level systems in vitro. This is thought to be primarily due 
to difficulty translating systems from 2D to 3D. The most significant challenge 
when developing 3D systems is the mass transport limitations encountered when 
scaling up to metabolically dense constructs over clinically relevant length scales. 
Reliance on passive diffusion of nutrients to sustain cellular metabolic 
activity limits overall construct size and metabolic density. Passive diffusion 
inadequately delivers nutrients over large length scales and limits the size and 
metabolic density of the construct. Furthermore, build up of nutrient and waste 
gradients within the construct reduces cell viability and disrupts cellular 
phenotype85. Inadequate transport of nutrients and waste has been correlated 
with a decrease in tissue quality as a function of distance from the nutrient 
source with the most distant regions becoming metabolically inactive or 
necrotic62,86. Due to these limitations, much effort in tissue engineering the 
fabrication has focused on strategies to enhance the mass transport properties of 
the construct, to maximize cellular viability and modulate signaling gradients for 
the control of cellular behavior and tissue formation. 
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Pure diffusional transport of nutrients and waste from cellularized tissue 
engineering systems limits the maximum geometric length of engineered tissues 
to between 150-200 IJm and restricts system metabolic density.11. 12 The 
development of complex, highly metabolic, tissue engineering therapeutics with 
clinically relevant dimensions requires the presence of pre-vascularized networks 
which transport nutrients and waste via convection and minimize the length over 
which diffusional processes occur. 87 Design of tissue engineering constructs that 
incorporate microvascular networks with sufficient mass transport characteristics 
holds the potential to increase both the size of in vitro tissue analogs and the 
capacity of the construct to support metabolically dense and clinically relevant 
cellular environments. Furthermore, implanted pre-vascularized tissue 
engineering constructs provide the ability to be surgically connected to host 
vasculature and reduce the effective distance for which invading host vessels 
must migrate in order integrate with the pre-vascularized networks. Optimization 
of these properties is essential to the in vitro development of complex tissues and 
organs such as the liver, brain, lung, and heart which require immediate 
perfusion post implantation for successful clinical outcomes. 
One approach to engineering vascularized tissues is the development of a 
functional pre-vascularized network in vitro prior to the implantation. Pre-
vascularization approaches may provide surgical anastomosis sites between the 
implant and the host and or facilitate rapid integration of the implanted 
vasculature with existing host vasculature networks to provide perfusion of 
nutrients and removal of waste from the implanted tissue. Perhaps the most 
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daunting task of this approach is the generation of functional perfusable 
microvascular networks in vitro. Development of these networks requires a highly 
multidisciplinary approach integrating concepts from cell and developmental 
biology with technologies from various material science sectors, all under the 
governing umbrella of fundamental engineering, fluid, and mass transport 
principles. 
Strategies for developing biomimetic PEG hydrogel systems for 
microvascular tissue engineering applications operate under the traditional tissue 
engineering paradigm. This strategy combines a dynamic ECM mimetic 
provisional scaffold; immobilized and free pro-vasculogenic signaling factors, and 
pro-vasculogenic cellular elements within a culture regime. More recently 
spatially mimicking the tissue microenvironment and recapitulating its structure-
function relationship has placed an emphasis on applying microfabrication 
technologies to biomaterial development. This adds an additional component to 
the traditional tissue engineering paradigm and suggests that synergistic benefits 
may occur if components are integrated under a structure function relationship. 
(Figure 15) In the following sections, each component of the tissue engineering 
paradigm will be discussed with respect to their application in microvascular 
tissue engineering. 
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Figure 15: Integration of the Traditional Tissue Engineering Paradigm with 
Microfabrication Technologies. Functional synergies arise when signals, cells and scaffolding 
are spatially integrated using microfabrication technologies to mimic the in vivo tissue 
microenvironment. Recreated from Hahn et al.36 , Khademhosseini et al. 88 and Tayalia et al.89 • 
4.2. PEG Hydrogels Modified with Vascular Biomimetic ECM 
Signals 
Initial biofunctionalization of PEG scaffolds incorporated whole ECM 
proteins, such as fibrinogen, into the polymer matrix.9o However, whole proteins 
present multiple adhesion and signaling domains that make elucidating specific 
bioactive mechanisms and targeting cell specific signaling difficult. Moreover, 
whole proteins are subject to denaturation during scaffold processing steps and 
isolation of whole protein extracts is costly and carries the risk for disease 
transmission .91 Therefore much interest has focused on the design of synthetic 
oligopeptide analogs that mimic the bioactive properties of their larger parent 
molecules. Multiple peptide sequences have been derived and have been shown 
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to bind to cell surface receptors and mediate cell adhesion and migration.92 
(Table 2 and Figure 16) 
Figure 16: Effects of RGD on Endothelial Cell Adhesion to PEG. Recreated from Hern et a1. 23 . 
Scale bar;;;: 100l-lm 
Peptide selection for MVTE scaffold biofunctionalization should mimic the 
matrix content of the vascular microenvironment. The microvascular matrix 
environment is known to be rich in both collagen and laminin and therefore the 
RGD peptide represents a robust option to promote both EC and pericyte 
adhesion. In addition it may be advantageous to employ peptides that exhibit 
selective or preferential cell adhesion. For example, REDV was shown to be 
selective for EC, while VAPG was shown to be adhesive for smooth muscle cells 
with little cross talk between adhesive domains. 38,39 Matrix based cell adhesion 
selectivity may be advantageous to help independently direct the response of EC 
and pericytes during vessel formation and maturation independent of soluble 
factors. 
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Table 2: Cell Adhesive ECM Mimetic Peptide Sequences. Recreated from West et af. 92. 
Cell Adhesive ECM Mimetic Peptide Sequences 
Peptide Sequence ECM Source 
RGD Fibronectin, vitronectin, laminin, and collagen 
YIGSR Laminin 
I KVAV Laminin 
REDV Fribronectin 
DGEA Collagen 
KQAGDV Fibrinogen 
VAPG Elastin 
4.3. PEG Hydrogels Modified with Pro-Vasculogenic Signaling 
Proteins 
Multiple pro-angiogenic signaling proteins have been covalently 
immobilized into PEG hydrogel scaffolds. VEGF, PDGF, and bFGF have been 
immobilized into PEG hydrogels and been shown to promote vascularized tissue 
growth. 51.93.94 The combination of VEGF and PDGF is particularly attractive due 
to its ability to mimic the signaling feedback necessary to favor stable pro-
tubulogenic phenotypes instead of the rapidly proliferating cobblestone 
morphology often seen in EC culture. 95 Functionalization of PEG scaffold 
surfaces with pegylated PDGF and RGDS in the presence of soluble VEGF has 
been shown to direct human umbilical vein endothelial cells (HUVECs) to form 
tubules instead of the cobblestone morphology observed with RGDS 
functionalization alone. 52 (Figure 17 A&B) 
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In addition to growth factors, cell-cell signaling molecules are thought to 
playa role in the formation of tubule like structures during vasculogenesis. 12 This 
cell-cell affect has been mimicked within synthetic PEG hydrogels by the 
covalent attachment of Ephrin-A1 into the scaffold. It was observed that HVUECs 
spontaneously formed tubule like structures with hollow lumens on the surface of 
PEG hydrogels functionalized with Ephrin-A1 and RGDS. 56 (Figure 17 C&D) This 
is a very interesting finding suggesting that the combination of adhesive ligands 
with pro-angiogenic proteins provides a bioactive signaling regime for 
spontaneous microvasculature formation. 
Figure 17: Immobilized Growth Factor Effects on 20 Endothelial Cell Morphology.(A) Light 
microscope images of Human Umbilical Vein Endothelial cells (HUVECs) on PEG hydrogels with 
immobilized PEG-PDGF-BB and PEG-RGOS (A) and PEG-ROGS alone (B) after 18 days of 
culture. Recreated from Saik et al. 52 Phalloidin-TRITC (red) and OAPI (green) confocal 
fluorescent micrographs of HUVECs seeded on PEG scaffolds with immobilized PEG-Ephrin A 1 
and PEG-RGOS Lumenized structures can be seen in length (C) and cross section (0) scale bar 
1 0 ~m. Recreated from Moon et al. 56 
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4.4. Proteolytically Degradable PEG Hydrogels for MVTE 
Although the bioinert nature of PEG hydrogels allows for high 
biocompatibility and low immunogenic responses it also renders the hydrogel not 
degradable by proteolysis. Furthermore, the stable ester linkages within the 
backbone of PEG make it non-degradable to hydrolysis at physiologic pH. 
Therefore in order to allow cellular migration and tissue formation to take place 
within a 3D PEG hydrogel matrix, it is necessary to engineer degradable domains 
into PEG hydrogels. 
Hydrolytically degradable PEG co-polymers are relatively simple to 
synthesize and allow for degradation, cell migration, and ultimately for tissue 
formation. 72,73 However, the degradation mechanism of these systems is 
controlled by polymer type, crystallinity, co-polymer ratios, hydrophilicity of the 
matrix, access of water to the polymer, and the pH of the environment. This 
myriad of factors makes modeling and prediction of polymer degradation difficult. 
Furthermore, hydrolytically degradable systems are not responsive to cell based 
proteolysis and therefore these systems struggle with the ability to match matrix 
degradation to tissue formation. Conversely, the degradation of proteolytically 
degradable PEG copolymers is directly related to the proteolytic activity of the 
cellular constituents within the scaffold. Therefore proteolytically degradable 
systems behave like an in vivo provisional matrix which allows for scaffold 
degradation at a rate that matches tissue formation. 
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Recently our group and others conjugated proteolytically degradable 
peptides sequences to PEG macromers. The system was designed with the 
degradable peptide sequence flanked by polymerizable PEG macromers to 
produce a PEG-Peptide-PEG block co-polymer capable of rapid polymerization 
followed by proteolytic degradation.2441 (Figure 18) The degradation of the 
hydrogel can be further tailored by designing a peptide sequence with variable 
substrate reactivity and cell specificity. 54 
Figure 18: Proteolytically Degradable Bioactive PEG Hydrogels. (A) Michael Type 
crosslinking of PEG hydrogels with adhesion peptides and MMP degradable linkers. (B,C) 
Invasion of fibroblasts into MMP sensitive hydrogel from 1-7 days. (0) Cell invasion rate 
depended on proteolytic activity of the peptide. Derived from Lutolf et al. 54. 
4.5. Cellular Elements for MVTE 
Development of vascularized tissue in vitro requires a multicellular system 
consisting of the organ functional parenchymal cells with the necessary cellular 
elements to facilitate blood vessel formation in vitro. Review of biology literature 
surrounding blood vessel development (see Figure 10-Figure 13) suggests that 
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the process is chiefly governed by endothelial and mural cells. Various 
endothelial cell (EC) types have been employed as the singular vessel forming 
elements. Human umbilical vein endothelial cells (HUVEC),96 rat lung 
microvascular endothelial cells,97 human dermal microvascular endothelial cells 
(MDMEC),98 and human embryonic stem cells (HESC)99 have been used to 
generate vessel like structures in vitro. Unfortunately, single cell type in vitro 
systems often suffer from regression due to lack of stabilization over long culture 
periods.43 Co-culture systems including a mural cell type along with EC have 
been utilized to generate long lasting and stable vessels. Human perivascular 
cells (PC)51, neural progenitors cells52, and smooth muscle cells42, have been 
incorporated into co-culture environments and have been shown to stabilize 
vessel formation with respect to controls. 
A very interesting finding by Rakesh Jain's research group demonstrated 
that a co-culture of human umbilical vein endothelial cells (HUVECs) and 10 T % 
(murine pericyte pre-cursors) self-assembled to form long lasting blood vessels 
within collagen hydrogels after implantation in vivo. The 10T % cells were shown 
to differentiate into pericytes in presence of HUVECs, and stabilize vessel 
structures where cultures without 10T % regressed shortly after self-assembly.10o 
53 
c 
_230 
~ 
o 180 
~ 
U) 130 
1 80 
21 28 35 
Tlme (day) 
Figure 19: Morphological and Functional Analysis of Self-Assembled Blood Vessel 
Networks. (A) Fluorescent micrographs of E-GFP expressing HUVECs (green) and (8) E-GFP 
expressing HUVECS (green) vessels perfused with rhodamine dextran (red) in vivo. (C) Temporal 
analysis of vessel density in co-culture (blue trace) and HUVEC only (red trace) constructs. (0) 
Co-culture of E-GFP expressing 10T Y:z pericytes (green) and rhodamine dextran perfused 
vessels (red) at 4 weeks of culture. 
This was an important proof of concept demonstrating the vasculogenic 
potential of the co-culture. However, the results were limited to in vivo 
tubulogenesis within a natural hydrogel Our research group has recently 
developed a fully synthetic photopolymerizable PEG hydrogel that drives the 
rapid self-assembly of stable HUVEC and 1 OT ~ microvascular networks in vitro. 
This novel hydrogel is fabricated with a PEG tethered biomimetic integrin peptide 
(PEG-RGDS) and a proteolytically degradable PEG derivative. The self-
assembled pre-vascular networks were shown to degrade the provisional 
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synthetic scaffold, secrete characteristic microvascular extracellular matrix 
proteins, laminin and collagen IV, and remain stable in culture for up to 30 
days.43 (Figure 20) This was a very important finding demonstrating that 
tubulogenesis could occur without functionalizing the scaffold with bioactive 
signaling proteins. This research represents a model for the proper integration of 
bioactive factors, synthetic hydrogel matrix, and co-culture system that is 
essential for recapitulating in vivo microenvironments capable of spontaneously 
generating microvascular networks. 
Collagenase-sensit ive pepti de: 
GGGPQGtlW GQGK 
------.,., Acrylate-PEG 
------.,0 Cell ad hesive ligand: 
ACRL- PEG-RGDS 
Figure 20: Schematic of Pro-tubulogenic Co-Culture in a Proteolytically Degradable PEG 
Hydrogel. (A) Schematic showing idealized hydrogel network fabricated with proteolytica"y 
degradable PEG derivative and ECM mimietic PEG-RGDS peptide conjugate and encapsulated 
pericyte precursoss (10 T Y2 and human umbilical vein endothelial cells (HUVECs). (8) Pro-
tubulogenic hydrogel shows tubule formation at 72 hr (green; HUVEC, red; 10 T Y2 and arrow 
indicating pre-lumen vacuole) Recreated from Moon et 81.43 
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4.6. Current Limitations in Microvascular Tissue Engineering 
Much progress has been made towards the development of vascularized 
constructs in vivo and in vitro. 101 Rapidly forming and long term stable networks 
have been produced on 20 substrates and within 3D constructs across a range 
of natural and synthetic materials within both in vitro and in vivo systems. 102 
However, current approaches have fallen short on several key aspects that are 
necessary for developing complex, bulky, vascularized tissues for regenerative 
medicine therapeutics and more pre-clinically relevant in vitro tissue models. 
These factors are divided into three areas described below: 
1.) Perfusable vasculature integrated across length scales 
The predominant body of work surrounding the growth and development 
of vascularized tissues in vitro has employed constructs with non-clinically 
relevant size scales. This is likely due to the experiments' early investigational 
nature and the scarcity of novel materials. Therefore a significant remaining 
challenge is scaling up the vascularized systems to bulky, organized and 
perfused constructs for therapeutic transplant or more robust in vitro tissue 
analogs. However, in vitro vessel scale up requires design considerations 
beyond increases in material quantities and overall dimensions; with unique 
scale up challenges to be considered at each stage of vessel nucleation, vessel 
growth, and maturation. 
During the initial vessel nucleation and early vessel development, 
advanced bioreactors are required to provide adequate mass transport of 
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nutrients, waste and key signaling molecules across large (mm-cm) length 
scales. Furthermore, the high cell seeding density required to drive early vessel 
nucleation (> 30x106 celis/mL) creates a highly regenerative but also pro-necrotic 
transport regime likely to have non-homogenous cell viability and tubulogenic 
activity. (Figure 9) Large scale bioreactor designs incorporating perfusion 103, 
pulsatile pumping 103 and a combination of both 104 have been reported to improve 
mass transport and alleviate detrimental nutrient and waste gradients. Other 
bioreactors have focused on microfabricated biomimetic designs with 
microchannels in poly(dimethyl siloxane) (PDMS)87,105 and collagen scaffolds 106 
to improve mass transport. However, these systems have not been directly 
applied to control and optimize vessel nucleation and growth. Therefore it is 
important to develop bioreactors specifically designed to optimize spatial tubule 
growth. 
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Figure 21: Effects of Distance from Vasculature on Nutrients and Bioactive Factor 
Concentrations. (A) Schematic demonstrating the affect of cells as metabolic sinks model on 
spatial distribution of nutrients and bioactive factors . (8) Kroghian based experimental modeling 
of oxygen profiles as a function of distance from a nutrient sources and number of cell layers. 
Recreated from Maida et al.62 
2.) Integration of vessel networks with in vitro perfusion sources 
Once the vessels networks have formed, it is critical that the networks 
integrate with a perfusion source across length scales (Figure 22). This will shift 
transport regimes from passive diffusion through the construct to lumen 
supported convection or flow through the vessel networks. This shift in transport 
mechanisms will enhance overall system transport properties (see Figure 22; 
FluxDiff«FluxVascularized) and shorten the constructs characteristic diffusion length 
(see Figure 22; O»d) resulting in spatially homogenous cell viability and 
prevention of vessel network regression. Furthermore, integration of vessel 
networks with a perfusion source across length scales will provide an opportunity 
to engineer a pro-anastomotic interface for rapid integration upon transplantation. 
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Figure 22: Shifting Transport Regimes in Vascularized Constructs. Non-vascularized 
transport is limited to diffusion-based transport with characteristic diffusion lengths (0) determined 
by the size of the overall construct size. Vascularized transport is utilizes perfusable vessel 
networks to transport mass via convection over large distances and diffusion over short distance. 
Characteristic diffusion lengths (d) in this system are defined by the distance between vessels. 
Beyond improving transport regimes and providing a pro-anastomotic 
interface for rapid integration in vivo, hierarchical organization and perfusion of 
vessel networks may also help to mature and generate tissue specific vessel 
networks. It has been previously shown within in vivo models that flow based 
maturation of early capillary plexuses leads to a more stable vessel network with 
appropriate physiologic transport functions.107-109 Furthermore, flow based 
maturation communicated through pressure driven circumferential strain and 
shear stress on the endothelium is thought to be responsible for tissue specific 
microvascular specialization.110-112 
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Together these factors outline the framework for a new paradigm to 
improve the quality of in vitro vascularized constructs. Beyond the well cited and 
exploited factors found to drive initial vessel self organization and network 
formation, vascularization strategies must allow for external perfusion and 
hierarchical organization across large dimensions. Such considerations will help 
to transition vascularized constructs from the early proof of concept stage to 
robust, bulky and clinically relevant systems. 
3.) Physiologic functionality of microvascular networks 
Development of cellular, biomaterial and bioreactor technologies to grow, 
perfuse, and integrate vessel beds across length scales provides a significant 
improvement over the current state of the art. However, these characteristics 
alone do not necessarily assure the physiologic functionality of microvascular 
networks. The hallmark function of the microvascular is to provide an ultra high 
surface area mass exchange system with the ability to be selectively permeable 
to various solutes depending on the tissue type the vasculature is supporting. 
Furthermore the microvasculature's transport properties are dynamic and can 
autoregulate to tissue demand for oxygen and nutrients as well as respond to 
systemic small molecule stimuli such as nitric oxide or humoral regulation via a 
variety of vasoconstrictor or vasodialator agents. 79 However, very little research 
has focused on applying and testing the mass transport functionally of in vitro 
microvascular networks, instead only focusing on single vessel constructs 113. 
Therefore one of the remaining challenges in engineering microvascular 
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networks in vitro is validating their ability function as a dynamic mass exchange 
system. 
4.) Incorporation of parenchymal cellular elements 
Much work has focused on the choice of scaffold, bioactive and cellular 
elements for the development of microvascular networks. However, these 
approaches often neglect the incorporation strategies and nutrient and signaling 
needs of tissue specific parenchymal cellular elements. The parenchymal cellular 
elements provide physiologic functionality for a given tissue type and therefore 
represent the most significant therapeutic contribution for regenerative medicine 
based therapeutics and are often the targets for pre-clinical drug development 
models in vitro. For example, a construct with highly functional and biomimetic 
liver vasculature in vitro provides very little hepatic function unless hepatocytes 
are present to metabolize waste and secrete hepatic compounds. Likewise, a 
liver cancer drug tested against a highly biomimetic microfabricated construct 
without hepatocytes carries little physiologic significance. Often the set of culture 
and tissue engineering parameters that are pro-vasculogenic may not support 
viability and function of the parenchymal elements. Therefore it is necessary to 
design a system that can support both microvascular network formation and 
parenchymal cell viability and physiologic function. 
The distinct soluble signaling, matrix components, and nutrient needs of 
parenchymal and pro-vasculogenic cells coupled with the dynamic nature of 
tissue development makes culture of heterogeneous cell populations non-
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obvious and requires special design considerations beyond simple combinatorial 
approaches. Some techniques have used systems seeded with pluripotent 
cellular elements that can differentiate into the pro-vasculogenic, pericyte, and 
parenchymal cellular elements.6,114 These approaches employ dynamic multi-
step culture conditions that first drive vessel formation and then direct 
differentiation into the parenchymal phenotype. In any case care must be taken 
to design systems that can independently direct formation of stable and 
functional microvascular networks while supporting parenchymal viability and 
preservation of phenotype in order to maintain tissue specific physiologic 
functionality. 
Another function of the parenchymal cells other than tissue specific 
function may be their ability to orchestrate or promote microvascular network 
formation and maturation.115 It is unclear during organism development, whether 
vessel networks and the nutrient and bioactive gradients they determine stipulate 
tissue specific formation or if parenchymal cells function to direct microvascular 
network properties. Regardless of the temporal development order, heterotypic 
cell interactions will likely play an important role in biomimetic tissue 
development.66 Developmental biology studies have provided useful insight into 
the temporal and hierarchal order of parenchymal and stromal cell roles during 
tissue development. It is important that in vitro tissue design must account for 
these relationships in developing whole tissue systems. 
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5.) Rapid in vivo anastomosis 
The largest remaining tissue engineering challenge for regenerative 
medicine based applications is the need for rapid construct anastomosis in vivo. 
60 Although biomimetic and physiologic functional transport regimes in vitro can 
increase construct size and performance, the lack of rapid anastomosis with the 
host vasculature in vivo will result in low overall implant viability and non-
homogenous tissue function across the thickness of the implant. 62 Much effort 
has focused on recruitment of host vessels through growth factor and other 
biochemical release from the implant. 93Despite this effort, host vessel 
anastomosis is still plagued by slow integration times. Moreover, the biochemical 
conditions that improve the anastomosis times often negatively affect both 
implant and host vessel quality 2851 and carry concerns about systemic toxic 
effects associated with very high and non-physiologic growth factor 
concentrations. 116,117 
Another approach to improving anastomosis times in vivo is the 
engineering of a pro-anastomotic interface. One embodiment of an improved pro-
anastomotic interface could result from the hierarchal integration of 
microvascular networks from single cell capillaries to larger diameter arterioles 
that are on the adequate size range for surgical anastomosis. Another example 
of a potentially pro-anastomotic interface could result from the presence of 
guidance microchannels at the implant interface that could allow for more rapid 
host vessel ingrowth into the construct. Furthermore, this approach can guide 
tissue in growth to specific strategically important anastomosis sties that will 
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facilitate rapid whole network perfusion. Both of these approaches have yet to be 
demonstrated in vivo or in vitro and are an intense topic of interest in our 
research group. 
4.7. Microfabricated Hydrogels for MVTE Applications 
Application of microfabrication technologies to hydrogels may provide a 
useful tool set to address some of the remaining challenges in MVTE. In 
particular hydrogel microfabrication technologies provide a means to spatially 
recapitulate the tissue microenvironment and help drive tissue formation. More 
specifically with respect to bridging length scales in MVTE constructs microfluidic 
hydrogels may provide sources to improve in vitro transport regimes and act as 
higher order conduits to facilitate biomimetic mass transfer across large length 
scales. The remainder of this chapter focuses on these technologies and their 
potential applications to MVTE. 
4.7.1. Direct Photolithographic Patterning of Hydrogels 
Photolithography refers to the process by which photons are spatially 
directed or focused to drive, either directly or indirectly, a photochemical reaction. 
This technology was developed by the semi-conductor industry to pattern 
integrated circuits with micron resolution. Spatially directed exposure of the 
photosensitive material can be achieved through a physical photomask, by 
focusing light via a laser scanning microscope 118, or through the use of a liquid 
crystal display projector119. Direct patterning of biomolecules within the hydrogel 
matrix has been shown by multiple groups to control cellular localization and 
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migration in 30.36,120,121 (Figure 23 C & D) PEG hydrogel structures have also 
been fabricated via additive photo patterning. 34,122 This technique enables the 
independent control of hydrogel content (cellular, biochemical, and 
biomechanical) and structure geometry.{Figure 23 A&B) 
Figure 23: Photolithographic Patterning of Hydrogels. (A,B) Additive photopatterning of 
PEGDA for the formation of multiple independent cellularized structures34,122 (C) Two photon 
laser photo patterning of PEG-RGDS into proteolytically degradable hydrogels directs cell 
migration in 3D (green=flourecent RGDS, Blue=DAPI, and red=phalioidin). 121(D) Photopatterning 
of GRGDS in agarose hydrogels directs cellular migration (green fluorescent GRGDS, 
red=phalloidin) 120 
Direct photolithographic hydrogel patterning for the fabrication of 
microvascular networks has largely remained absent from the literature for 
multiple reasons. Although cells can be patterned and their migration spatially 
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directed, the formation of patent EC lumens using this techniques has not been 
reported. Furthermore, it is conceptually and practically difficult to connect 
lithographically patterned cell structures to macroscale perfusion apparatus 
necessary to promote perfused vascularized tissue engineering constructs. 
Finally, although cellular migration can be spatially directed using this technique, 
the additive fabrication of patent microchannel requires the exposure of large 
non-channel areas. This region of interest (ROI) patterning via laser scanning 
lithography (LSL) is difficult due to the time associated with pattering large ROls 
using the iterative raster scanning algorithm. More recently, Kloxin et al has 
developed a photocleavable PEGDA hydrogel derivative.123 (Figure 24A) In this 
work the author demonstrated the ability to photocrosslink hydrogels with one 
wavelength of light and photodegrade the bulk hydrogel with as conventional UV 
lamp or spatially tailor 3D regions using a two-photon light source and a laser 
scanning microscope. (Figure 24 B & C) This is a breakthrough in the 
development of 3D hydrogel microchannels in a material removal scheme 
compatible with large structure fabrication. 
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Figure 24: Photodegradable PEGDA Derivatives. (A) Schematic of photocleavable PEG 
derivative ad network before and after cleavage. (8) Schematic of two photon irradiation and 3D 
channel patterning in phase contract and (C) fluorescent imaging modes Adapted from Kloxin et 
al 123 
4.7.2. Replica Molded Hydrogels 
Perhaps a more direct method to fabricate microarchitectures within PEG 
hydrogels is through soft lithographic replica molding of pre-polymer solutions. 
Soft lithography was introduced by. Whitesides' research group as a means to 
fabricate microfluidic channels within PDMS. The general process is outlined in 
Figure 25 where the photo resist is deposited on the substrate (a-b), a mask is 
fixed in place and the photosensitive material is exposed to UV (c-d), liquid pre-
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polymer is poured over the mold with structures in relief and cured. Finally the 
cured polymer is peeled from the photoresist master to observe 
microarchitectures in relief (e_f).124 
IN light exposure: 
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Figure 25: Soft lithography Schematic. photo resist is deposited on the substrate (a-b), a 
mask is fixed in place and the photosensitive material is exposed to UV (c-d), liquid prepolymer is 
poured over the mold with structures in relief and cured, cured polymer is removed to observe 
microarchitectures in relief (e-f) Recreated from Weibel et a/124 , 
This technique has been broadly applied to a wide range of polymer system for 
applications ranging from whole organisms sorting 125,automated microfluidic cell 
culture systems 126, to microarrayed pillars for biosensing and cellular diagnostic 
applications 127,128. 
Recently it has been shown that hydrogels and other attractive 
biomaterials can be fabricated into microchannel networks using this same 
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technique. These networks have been used to facilitate convective and diffusive 
mass transport 129, spatiotemporally introduce reagents into the scaffold bulk 
from perfused channels 130 and direct cell localization within the microchannel 
lumen 131 and the scaffold bulk 132,133. Most recently, multilayer microfluidic 
devices have been developed combining poly(dimethylsiloxane) (PDMS) and 
hydrogel microarchitectures to study cell migration 134 and spatially control 
microenvironment properties within perfused channels 135. 
Early fabricated system in this field involved the micromachining of silicon 
and pyrex 87 to build microchannel architectures. The materials utilized in these 
devices performed poorly as tissue engineering scaffolds and did not encourage 
microvascular formation. However, replica molding techniques using a sucrose 
sacrificial coating and poly(glycerol sebacate) (PGS) as the molding material 
produced microchannels that supported media perfusion, EC adhesion, and 
yielded a confluent monolayer at 14 days of culture. 136 (Figure 26) 
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a) II b) 
Figure 26: PGS Microchannels. (A) Replica molding fabrication schematic (8) Microchannel 
Network geometry (C) flexible and parallel microchannel networks (0) endothelialized 
microchannel networks at 14 days. Recreated from Fidkowski et a1 136. 
The first replica molding of perfusable hydrogel microchannels began to 
allow for cells to be encapsulated within the hydrogel bulk and for evaluation of 
system mass transport properties. These systems probed spatiotemporal mass 
transport and cell viability characteristics associated with microchannel networks 
within agarose 129 and calcium alginate 130 tissue engineering scaffolds as a 
function of cell type, cell seeding density, and perfusion rate. (Figure 27) 
Although this research laid the ground work for microfluidic hydrogel fabrication , 
these systems do not exhibit any tendency of the scaffold to direct tissue 
formation or produce microvascular tubule networks composed of cells . This was 
primarily due to the lack of biofunctionality of PGS, agarose, and calcium alginate 
based materials. 
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Figure 27: Mass Transport within Microfluidic Hydrogels. (A) FllC 8SA diffusion from 
perfused agarose hydrogels as a function of time. 129 (8) Spatial temporal diffusion of fluorescein 
(green) and rhodamine (red) of perfused calcium alginate hydrogels.(C) Calcein AM (green, 
positive cell viability stain) only labels cells in regions nearest the perfused channel. 13o 
A novel method for the fabrication of microchannel networks within highly 
bioactive hydrogel matrices was introduced by the Golden et a/133• in 2007. This 
method utilized replica molding to fabricate a sacrificial gelatin microstructure 
mesh which was embedded within both collagen and fibrin hydrogels and 
dissolved away to yield a microchannel. (Figure 28) This work re-iterated the 
capability to seed EC within the microchannel network but also encapsulated a 
second cell type, fibroblasts, in the hydrogel bulk.133 
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Figure 28: Microfluidic hydrogels fabricated via a sacrificial poragen. (A) Schematic 
illustrating use of replica molded gelatin meshes as a sacrificial poragen. (8) Collagen hydrogel 
with microspheres flowing through channels. (C) Layering of two microchannel networks to form a 
pseudo 3D system. (0) Endothelialized microchannel networks after culture for 5 days. Recreated 
from Golden et a/133 
This application of a biocompatible sacrificial poragen process to highly bioactive 
hydrogel materials (Collagen, Fibrin and Matrigel) was an important contribution 
to the literature. However this work fell short in addressing several key limitations 
in developing vascularized tissues in vitro. Most importantly the author did not 
encapsulate any tubule forming cellular elements within the hydrogel bulk and 
therefore failed to demonstrate the systems potential to support self-assembled 
microvascular networks in vitro. Coinciding with this the researcher didn't show 
the ability to integrate fabricated and endothelialized channels with interstitial 
tubule forming elements located within the hydrogel bulk. This is important when 
trying to design systems that integrate perfusion components across length 
scales. 
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4.7.3. Microfabricated Hydrogels Embedded within PDMS Housings 
In vivo organization of microvascular tissue hierarchies is often composed 
of spatially distinct heterogeneous physical and biochemical regions. Each region 
provides a specific function that is unique to the tissue and important to a 
maintaining a structure function relationship at the tissue and organ level. (see 
section 4.6 Current Limitations in Microvascular Tissue Engineering - #3 Role of 
Parenchymal cell) Often spatial and temporal recapitulation of physical, 
biochemical and cellular elements in biomimetic patterns cannot be 
accomplished with a single microfabrication technique and therefore it is often 
necessary to employ multiple microfabrication modes within a single construct. 
One strategy that is being employed to address some logistical problems 
associated with microfluidic hydrogels is the use of an external PDMS housing. 
Despite the significant limitations of PDMS alone as a microfluidic scaffold, 
PDMS has advantages in composite hydrogel-PDMS systems. PDMS provides a 
readily fabricated, transparent, imaging compatible, robust outer housing for easy 
handling and maintenance of a sterile culture environment without the use of 
complex support apparatus (see Supplemental material Choi et aI 130).137 
Furthermore, the combination of PDMS microfluidic networks with inlaid regions 
of cell laden hydrogels provides a means to precisely control spatial gradients 
and flow regimes while harnessing the biomimetic aspects of a hydrogel as a 
favorable scaffolding material.134,135,138 (Figure 29) 
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Figure 29: Hydrogels inlaid within PDMS housings for controlled gradients and flow 
regimes. (A) Use of a dual channel approach to establish controllable concentration gradients. 138 
(8) A similar dual channel system with hydrogel elements (red) microinjected within a region 
between cell seeding regions (middle;blue) and perfused channels (edges blue and green).134 (C) 
Use of laminar flow regimes to spatially control thermal polymerization of PEG pre-polymers for 
partitioning of reagents within PDMS microfluidic channels.135 
This techniques result in systems with interesting properties and the ability to 
study fundamental cell interaction in a highly repeatable in vitro environment. A 
noticeable weakness of these systems is the reliance on thermal polymerization. 
In the case of Chun et a/134. (Figure 29A,B) the inlaid hydrogel geometry is 
determined by the shape of the PDMS housing and this system requires 
separate microinjection access ports. In the case of Wong et al. 135 (Figure 29 
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C,D) fabrication of hydrogel structures is limited to simple straight segments 
directly related to the partitioning of fluid due to laminar flow regimes within 
PDMS microchannels. 
Development of fabrication techniques that allow for independent control 
over PDMS housing and hydrogel geometry would be advantageous to the 
development of complex multi layer tissue analogs in vitro. Recent efforts have 
combined softlithography and photolithography as a method to fabricate PEG 
hydrogel microstructures within PDMS microfluidic channels for fabrication of 
cellular arrays 139 mUlti-component patterns 140 and robust hydrogel microparticles 
of easily tunable geometries within microfluidic channels.141-143. (Figure 30) 
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Figure 30: Hydrogel Microfabrication Approaches within PDMS housings (A) Schematic of 
photolithographic patterning of PEG structures within PDMS housing and (8) representative 
images of structure fidelity. 140 (C) Micromolded cell laden PEG structures within a PDMS 
microfluidic channel. 139 
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Although these studies report high cell viability, the hydrogel molecular 
weight « 1000 Oa), hydrogel concentration (>50 wt%), and photoinitiator 
concentration (>1 %) employed have been found to be inhibitive of tissue 
formation and scaffold remodeling by cellular elements. Furthermore, the use of 
free-radical photo polymerized poly(ethylene glycol) dimethacrylate (PEGOMA) or 
poly(ethylene glycol) diacrylate (PEGOA) does not allow for proteolytic or 
hydrolytic degradation under physiologic conditions. This severely limits the 
ability of these systems to allow for cell driven in vitro tissue development and 
ultimately the applicability to recapitulate the cellular microenvironments. Much of 
our current work has focused on adapting these fabrication methods to highly 
biomimetic and bioactive hydrogels that support tissue formation. 
4.8. Current Limitations in Microfabricated Hydrogels for MVTE 
Applications 
1.) Application of microfabrication techniques to hydrogels that support 
and guide tissue formation 
Early application of hydrogel microfabrication techniques focused on 
natural materials, such as agarose 129 and calcium alginate 130, that have not 
been shown to possess vasculogenic potential. More recently, pro-tubulogenic 
materials such as, collagen I and the reconstituted basement membrane analog, 
Matrigel, have been replica molded to form microfluidic networks.133 However, all 
of these natural materials suffer from batch to batch variability and with the 
exception of alginate carry immunogenic concerns due to their generation from 
76 
animals. In particular, Matrigel possess a variety of ECM components at 
unknown quantities and purities. This severely limits the ability to tailor 
biochemical and biomechanical properties and reduces clinical applicability. In 
order to maintain clinical significance, microfabrication techniques should be 
applied to hydrogel materials that are highly biocompatible and non-immunogenic 
but retain the ability to drive microvascular network formation. This is a critical 
remaining challenge to translating pro-vasculogenic hydrogels from the 
laboratory to the clinic. 
2.) Fabricated Microfluidic Channel Integration with Self-Assembled 
Vessel Networks 
A wide variety of microfluidic hydrogel network designs have been 
employed to mimic the in vivo microvasculature. Models have been developed to 
mimic in vivo flow regimes 136, minimize energy considerations 144.145, preserve 
wall shear stress and146 maximize system mass transport147 However, efforts to 
develop hierarchal organization and integration of fabricated channels with self-
assembled vessel networks has been largely absent from the literature. Vessel 
network integration with fabricated microchannels would allow for controlled 
perfusion to occur across large length scales and would represent a material 
science breakthrough demonstrating integration of fabricated structures with self-
assembled microvascular networks. In order to accomplish this task much care 
must be taken to engineer the interface between the perfused microchannel 
solution and the hydrogel wall containing microvascular networks. It is likely that 
an interplay between physical structures, proper flow and pressure conditions, as 
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well as biochemical considerations must be optimized in order to achieve an in 
vitro anastomotic interface between microvascular networks and fabricated 
structures. 
3.) Incorporation, Integration and Support of Parenchymal Cellular 
Elements 
Development of materials and techniques that are conducive to 
microfabrication, microvascular network formation and have been engineered to 
integrate across length scales still neglect considerations to incorporate the 
functional parenchymal elements into the tissue. Furthermore, special concern 
must be taken to assure that culture conditions that support microvascular 
network formation and integration with microfluidic networks also support 
parenchymal cell viability and normal physiologic functions. Finally, whether 
parenchymal cells are incorporated in separate fabrication steps or are 
concurrently seeded with pro-vasculogenic cultures, care must be taken to 
facilitate parenchymal integration with microvascular networks. 
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5. Chapter 5: Overview of Thesis Objectives 
Although significant progress in pre-vascularized materials and 
microfluidic hydrogels has been demonstrated, there is little or no results 
showing that these technologies can be combined to recapitulate hierarchical 
vascular organization in vitro and improved anastomotic constructs in vivo. 
Moreover, the mass transport functionality of self-assembled microvascular 
networks has not been shown in vitro due mostly to the lack of ability to 
externally perfuse in vitro microvascular networks. Finally, although functional 
microvascular networks alone provide advantageous in vitro culture systems and 
have therapeutic potential , these systems have not incorporated the tissue 
specific parenchymal cellular elements. Together these factors have inspired a 
governing research objective to integrate microfabrication technologies with 
robust perfusion apparatus and pro-tubulogenic hydrogels. (Figure 31) 
Subsequent chapters will focus on novel research that begins to address these 
limitations and advance hydrogel microfabrication technologies for microvascular 
tissue engineering applications. 
Integration of Technologies 
~------------------~ 
Microchannels Perfusion Apparatus 
M~ou" roL 8''''''''1 !010 
Figure 31: Integration of Microfabrication Technologies with a Self-Assembling Pro-
Tubulogenic Hydrogel. 
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6. Chapter 6: Multilayer Microfluidic Poly (ethylene 
glycol) diacrylate Hydrogels 
6.1. Introduction 
Development of robust, in vivo-like tissues in vitro holds the potential to 
create regenerative medicine therapeutics, provide more physiologically 
significant pre-clinical models and supply a pharmacological and toxicological 
screening platform that reflects in vivo systems in both complexity and function. 
Pure diffusional transport of nutrients and waste from cellularized tissue 
engineering systems limits the maximum geometric length of engineered tissues 
to between 150-200 IJm and restricts system metabolic density.11, 12 Design of 
tissue engineering constructs that incorporate microvascular networks with 
sufficient mass transport characteristics holds the potential to increase both the 
size of in vitro tissue analogs and the capacity of the construct to support 
metabolically dense and clinically relevant cellular environments. 
Multiple microfabrication techniques have been employed to improve 
mass transport properties in tissue engineering scaffolds. Perhaps the most 
important microfabrication technique to improve scaffold mass transport 
properties is the fabrication of microfluidic networks in tissue engineering 
constructs using softlithographic replica molding techniques. Despite this 
significant advancement, application of microfluidic channels to 
photopolymerizable synthetic hydrogel materials has remained absent from the 
literature. This is likely due to the logistical challenges associated with general 
handling and reliably connecting perfusion apparatuses to microfluidic hydrogels. 
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Systems employed to address these limitations were complex and cumbersome 
to the spread of the technology (Figure 32A). A more amenable and robust 
system design that can be rapidly tailored would allow for a broader adoption of 
microfluidic hydrogels. A novel system introduced by Chorbak et al utilized a 
microfabricated PDMS housing to control perfusion to the hydrogel. (Figure 32) 
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Figure 32: Supporting Apparatuses for Microfluidic Hydrogels. (A) Complex machined 
components needed to perfuse and handle a microfluidic hydrogel. (8) A simpler system utilizing 
a PDMS housing to control perfusion of collagen tube, Recreated from Choi et a/130 and Chrobak 
et al. 137 
We report a simple, robust, multilayer replica molding technique in which 
PDMS and poly(ethylene glycol) diacrylate (PEGDA) are serially replica molded 
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to develop microfluidic PEGDA hydrogel networks embedded within 
independently fabricated PDMS housings. This technique allows for the 
production of perfusable PEGDA networks independent of overall scaffold 
geometry. In addition, we show the ability to quantify and modulate spatial 
temporal construct mass transport properties and cell viability. Together these 
techniques represent a significant contribution towards the development of 
metabolically dense, complex 3D tissue analogs in vitro. 
6.2. Objectives 
The objective of this study was to fabricate perfusable microfluidic 
networks within PEGDA hydrogels. More specifically it was our aim to 
characterize the mass transport characteristics of the system by: 
• Analyzing spatiotemporal mass transport across a range of molecular 
weight solutes and various hydrogel formulations 
• Determining spatiotemporal cell viability profiles in perfused PEGDA 
hydrogels when compared to static culture systems 
• Determine optimal microfluidic channel spacing for maximum cell 
viability 
6.3. Materials and Methods 
6.3.1. Cell Maintenance 
NIH 3T3 fibroblasts, passages 3-10, (ATCC, Manassas, VA, USA) were 
cultured in Dulbecco's Modified Eagle Medium (DMEM; Sigma) supplemented 
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with 10% (v/v) heat inactivated fetal bovine serum (FBS; Biowhittaker, 
Walkersville, MO, USA), 2mM L-glutamine, 500 U penicillin, and 100 mg/mL 
streptomycin at 3r C in 5% CO2 to 90% confluence prior to seeding. 
6.3.2. Poly( ethylene glycol) Diacrylate (PEGDA) Synthesis 
6 kOa PEGOA was synthesized according to previously published 
methods35. Briefly, PEGOA with a molecular weight (MW) of 6000 g/mol was 
prepared by combining 0.1 mmol/mL dry poly(ethylene glycol) (MW 6000 g/mol, 
Fluka), with 0.4 mmol/mL acryloyl chloride, and 0.2 mmol/mL triethylamine in 
anhydrous dichloromethane (OCM, Sigma) and stirred under argon overnight. 
The resulting solution was washed with 2 M K2C03 (Sigma) and separated into 
aqueous and OCM phases to remove hydrochloric acid. The OCM phase was 
subsequently dried with anhydrous MgS04 (Sigma), and PEGOA was 
precipitated in diethyl ether (Fisher), filtered and dried under vacuum. (Figure 33) 
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Figure 33: Reaction Schematic for Synthesis of poly(ethylene glycol) diacrylate (PEGDA). 
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6.3.3. Preparation of PEGDA pre-polymer solutions for Spatiotemporal 
Transport Studies 
Solutions were prepared containing 6 kDa PEGDA in PBS (pH 7.4) to 
yield final concentrations of 5, 10 or 20% (w/v). Irgracure 2959 (Ciba, 100 mg/mL 
in 100% ethanol) was added to the hydrogel pre-polymer solution at 30 IJLlmL. 
6.3.4. Preparation of PEGDA pre-polymer solution and acryloyl - PEG -
RGDS for Spatiotemporal Cell Viability Studies 
6 kDa PEGDA was dissolved in sterile PBS (pH 7.4) to yield a final 
concentration of 10% (w/v). 3 mM acryloyl-PEG-RGDS, synthesized according to 
previously reported methods41 (Figure 34), was added to the pre-polymer 
solution to allow for cell adhesion and promote cell cycle progression.(see 
Appendix for bioconjugate characterization) NIH 3T3 fibroblasts were trypsinized, 
counted and suspended within the PEGDA pre-polymer solution at 11 x106 
cells/mL. The celi/PEGDA pre-polymer solution was replica molded to yield a 
microfluidic hydrogel as described in section 2.1.3 Fabrication of Multilayer 
Microfluidic Hydrogel. Cylindrical cell laden (11 x1 06 cells/mL) hydrogel 
constructs, 3 mm in diameter and height, were placed in well plates containing 1 
mL of DMEM and used as static controls. Encapsulated cells were cultured for 0-
72 hr under perfused or static conditions. 
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Figure 34:Reaction Schematic of Acryoyl-PEG-RGDS. The amino acid sequence RGDS is 
reacted with acryoyl-PEG-N-hydroxysuccinimide in anhydrous dimethylsulfoxide (DMSO) in the 
presence of base for 24 h at room temperature protected from light. 
6.3.5. Multilayer Microfluidic Device Fabrication 
6.3.5.1. Fabrication of SU-8 Photoresist Masters 
Glass slides were cleaned and hydroxylated in piranha solution (7:3 v/v 
solution of H2S04: 30% H20 2) for 30 minutes and dehydrated for 15 minutes at 
200· C prior to spin coating. SU-8 2100 (Microchem) was spun coat at 1000 rpm 
for 40 seconds to generate a 350 IJm thick substrate and SU-8 2050 (Microchem) 
was spun coat at 1000 rpm for 40 seconds to generate a 100 IJm thick substrate. 
Photoresist substrates were exposed via a Mask Aligner (SUSS) using 20,000 
dpi transparency masks (CAD/ART Services). All other photoresist processing 
parameters were derived from manufacture recommended protocols. 350 IJm 
photoresist masters used to mold the PDMS housings, were cleaned with 100% 
ethanol, dried with filtered air, and molded to PDMS. 100 IJm photoresist masters 
used to mold the PEGDA microchannels were cleaned with 100% ethanol, dried 
with filtered air and coated with SigmaCote (Sigma) to prevent adhesion of 
PEGDA structures to photoresist masters. 
6.3.5.2. PDMS Housing Fabrication 
PDMS (Sylgard 184) was mixed (10:1; silicone elastomer: curing agent), 
degassed, and cured to 350 IJm photoresist masters for 3 hours at 65° C (Figure 
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35, Step 3). PDMS housings were removed from the photoresist master, access 
ports were bored with a 1 mm biopsy punch and then polyethylene tubing was 
inserted into the access ports and sealed through compression fitting. All PDMS 
housings were treated with the photoinitiator (2,2-dimethoxy-2-phenyl 
acetophenone in n-vinylpyrrolidone, 300 mg/mL) (Sigma) for 5 min to promote 
free radical induced interfacial polymerization of the PEGDA prepolymer solution 
to the PDMS housing. Excess photoinitiator was removed via sequential rinsing 
with 100% ethanol followed by ultrapure H20 and then dried with filtered air. 
6.3.5.3. Fabrication of Multilayer Microfluidic Hydrogels 
Acetophenone-coated PDMS housings were aligned and overlaid with the 
SU-8 2050 photoresist masters treated with SigmaCote. PEGDA prepolymer 
solutions containing cells or PEGDA alone were injected into the housing around 
the channel mold and exposed to a long wavelength UV lamp (365 nm, 10 
mW/cm2) for 2.5 minutes (Figure 35, Step 5). In order to form 3D microfluidic 
networks, acetophenone-coated PDMS housings were sealed against a flat 
substrate and PEGDA prepolymer solutions were injected into the housing and 
under crosslinked via a 1 minute UV exposure to form a blank slab (Figure 1, 
Step 8). The PDMS/PEGDA microchannel mold and the under exposed blank 
slab were brought into contact and exposed to UV for 2.5 minutes to graft the 
hydrogel blank slab to the hydrogel with channel in relief (Figure 35, Step 9). For 
all experiments reported herein, the PDMS housing with an embedded PEGDA 
microfluidic hydrogel was conformally sealed to cover glass; polyethylene 
perfusion tubes were connected to the inlet reservoir and outlet syringe pump. 
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Perfusion was initiated at 600 IJLlhr using a syringe pump (Harvard Apparatus) in 
withdrawal mode. 
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Figure 35: Fabrication schematic of PDMS/PEGDA microfluidic networks. Serial replica 
molding of PDMS and PEGDA to photoresist masters produces a perfusable PEGDA microfluidic 
channel embedded within an exterior PDMS housing. The PDMS/PEGDA construct, Mold A, can 
be sealed to coverglass for imaging after step 5 or crosslinked to a PEGDA blank slab, Mold B, to 
produce a 3D microchannel environment (Step 9}.Recreated from Cuchiara et al. 148 
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6.3.6. Spatiotemporal Diffusion Profile Analysis 
Immediately post device fabrication and sealing to coverglass, acellular 
PDMS/PEGDA microfluidic hydrogels were perfused (600 IJUhr) with model 
transport molecules at various molecular weights (305 Da toluidine blue, 3 kDa 
dextran fluorescein, or 10 kDa dextran fluorescein). Images of the spatiotemporal 
fluorescent diffusion profiles were taken at 0, 1, 2, 4, 8, and 12 hours post 
perfusion using a fluorescent stereoscope (Zeiss Discovery V 8 Stereo Scope, 
1x, EXFO X-cite light source) and a color CCD camera (Jenoptik, 5 megapixel, 
16-bit). Images were analyzed using ImageJ (NIH) and spatial intensity profiles 
were generated using the plot profile function to determine spatial fluorescent 
intensity at each time-point. Intensity profiles were normalized to maximum 
intensity and plotted as a function of distance from the microchannel wall, 
perfusion time, and molecular weight of the transport molecule. 
6.3.7. Mass Transport Models and Effective Diffusivity Parameter Fitting 
The diffusion of solutes from the perfused microchannel was assumed to 
occur in only one dimension (outward from the channel). This assumption leads 
to the application of Fick's Second Law of Diffusion to the system (Equation 1) 
. and its solution (Equation 2). Where Cs is the concentration of solute, Deff is the 
effective diffusivity as a function of solute molecular weight (S) and PEGDA 
matrix concentration (M). Co is the concentration of the solute within the perfused 
microchannel. 
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dCs = D (S M) d 2Cs 
dt 'if' dx 2 
Equation 1: Fick's Second Law of Diffusion. 
Equation 2: Solution to Fick's Second Law of Diffusion. 
The assumption of diffusion only occurring in one dimension is validated 
by operating the perfusion system at high Peclet numbers (Pe) which show 
convective forces far exceeding diffusive forces. (Equation 3) For the toluidine 
blue and dextran system, Peclet numbers ranged from 1400-4300 respectively. 
These values are much larger than the ratio of channel length to channel height 
(Llhc = 100) therefore suggesting that solute concentration does not vary as a 
function of length along the channel. 
Equation 3: Dimensionless Peclet Number and Comparison to Microchannel Geometry. 
Effective diffusivity of the hydrogel-solute system was determined by 
iterative parameter fitting of the measured spatiotemporal diffusion profiles to the 
solution of a one dimensional, non-steady state, first order Fickian diffusion 
equation using Igor Pro (WaveMetrics) software package. All data sets 
converged to the given solution for effective diffusivity across a range of initial 
estimates 
Effective diffusivity as a function of solute molecular weight (toluidine blue 
MW=305 Da, 3 kDa and 10 kDa dextran) in water was determined using the 
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Stokes- Einstein relationship 149. Through methods presented by Fournier et 
al. 149, where solute molecular radius (a) can be calculated by assuming the 
solute has a given molecular weight (MW), is spherical in shape and has a 
uniform density (p) (Equation 4). Substituting the molecular radius (a) into the 
Stokes-Einstein equation (Equation 5) provides values for effective diffusivity in 
water as a function of molecular weight. Here R is the ideal gas constant, T is 
temperature in degrees Kelvin, ~ is the viscosity of water at temperature T, and 
NA is Avogadro's number. 
( )
1/3 
a= ::: 
Equation 4: Molecular Radius as a Function Solute Molecular Weight. 
D = RT 
Water 6;rpnN A 
Equation 5: Solute Effective Diffusivity as a Function of Solute Molecular Radius. 
6.3.8. Spatiotemporal Cell Viability Analysis 
Spatiotemporal cell viability profiles were obtained at 0, 24, 48, and 72 hr 
post encapsulation at regions ranging from 0-1500 ~m from the perfused 
microchannel or from the edge of the static tissue cylinder. 3T3 cell viability was 
assessed using a Live/Dead assay (Calcein AM/Ethidium homodimer, 
Invitrogen). The viability staining was imaged using a confocal microscope (Carl 
Zeiss Inc. LSM 5 Live, 20X (NA 0.8) objective, FOV= 318 x 318 ~m, vertical z-
stack: 1 ~m slices, 50 slices per region). Images were tiled outward from the 
microchannel wall at 300 ~m intervals between 0-1500 ~m to determine cellular 
91 
viability as a function of distance from the microchannel. At each region the ratio 
of live cells (Calcein AM positive) to total cells (Calcein AM + Ethidium 
homodimer) was analyzed as a function of radial distance from channel and 
culture time. 
6.4. Results and Discussion 
6.4.1. Fabrication of Multilayer Microfluidic Hydrogels 
Here we describe a multilayer softlithographic fabrication technique 
wherein PDMS and PEGDA were serially replica molded to form a microfluidic 
PEGDA hydrogel embedded within an external PDMS housing. Serial replica 
molding of PDMS followed by PEGDA, formed robust, perfusable hydrogel 
microchannel networks with channel diameters ranging from 50-500 IJm and 
aspect ratios from 5: 1 to 1 :2. (Figure 36). This fabrication process, along with the 
rapid and mild photocrosslinking conditions utilized for PEGDA hydrogel 
formation, allowed for encapsulation of cells within the hydrogel matrix with 
minimal cytotoxicity (Figure 40 & Figure 41, t=O hr). 
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Figure 36: Multilayer microfluidic PEGDA hydrogel. (A) Isometric view of PDMS/PEGDA 
microchannel device perfused with toluidine blue, (8) Diffusion of toluidine blue into PEGDA 
diffusion chamber (10 x 10 mm) from a single 50 IJm channel with red hashed line indicating 
location of cross sections in C & D. Recreated from Cuchiara et a/ 148 PDMS/PEGDA device 
cross sections with a (C) 3: 1 and (D) 1:2 PEGDA microchannel aspect ratio. 
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6.4.2. Molecular Weight Effects on Spatiotemporal Transport Gradients 
Inadequate nutrient and waste mass transport limits the size, complexity 
and clinical functionality of tissue engineered constructs. Optimization of nutrient 
and waste mass transport coupled with control over spatiotemporal signaling 
gradients provides the ability to maximize cell viability, spatially control cell 
behavior and direct tissue formation. We demonstrated a microfluidic PEGDA 
hydrogel system that supports pressure driven convective transport as well as 
diffusional transport mechanisms. Spatiotemporal molecular gradients were 
shown to vary as a function of solute molecular weight (Figure 37) and hydrogel 
concentration (Figure 38). As expected, diffusional transport of higher molecular 
weight solutes with larger hydrodynamic radii occurred at a slower rate when 
compared to that of lower molecular weight solutes (Figure 37 & Figure 38). 
Toluidine blue (MW=305 Da) exhibited the highest effective diffusivity (1.75 x10-5 
cm2 /sec) while 3 kDa dextran fluorescein (1.23 x1 0-7 cm2 /sec) and 10 kDa 
dextran fluorescein (2.6 x1 0-9 cm2 /sec) exhibited lower effective diffusivities in 
proportion to their increasing molecular radius. (Figure 38D) 
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Figure 37: Solute molecular weight effects on PEGDA spatiotemporal diffusion profiles. 
Diffusion of multiple molecular weight solutes; toluidine blue (green , MW= 305 Da), 3 kDa 
Dextran fluorescein (blue) and 10 kDa Dextran fluorescein (red) in 10% (w/v) 6 kDa PEGDA 
hydrogels. Advancing profiles represent increasing time from 1 to 12 h (Inset) Expanded view of 
diffusion profiles shows dextran hydrogel penetration depths on the order of hundreds of microns 
compared to millimeters for low molecular weight toluidine blue. Reproduced from Cuchiara et 
al. 14$. 
In addition to solute molecular weight effects on spatiotemporal molecular 
diffusion gradients, PEGOA hydrogel concentration was shown to affect system 
transport properties (Figure 38). Increases in hydrogel concentration from 5 to 
20% (w/v) were shown to be inversely related to solute diffusion rate and the 
effective diffusivity of the hydrogel-solute system (Figure 380). At the low 
hydrogel concentration (5 %), toluidine blue had the highest effective diffusivity 
(1.86 x1 0-5 cm2 /sec). However, when increasing the hydrogel concentration to 10 
and 20% the effective diffusivity of toluidine blue decreased to 1.75 x1 0-5 and 
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8.45 x1 0-6 cm2 /sec respectively (Figure 380). This trend was attributed to the 
decrease in average hydrogel pore size as a function of increasing PEGOA 
concentration. Modulation of diffusion gradients by varying polymer physical 
properties and solute molecular weight provides a useful tool to control soluble 
spatiotemporal signaling gradients and to direct cell migration and tissue pattern 
formation in vitro. 
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Figure 38: PEGDA hydrogel concentration effects on transport properties. (A-C) 
Spatiotemporal toluidine diffusion profiles at 10,200, and 400 min of perfusion for 20% (red), 10% 
(green) and 5% (w/v) (blue) PEGOA hydrogels, (0) Measured effective diffusivity, fit from a 10 
non-steady state Fickian diffusion model, plotted as a function of solute molecular weight and 
PEGOA hydrogel concentration. Recreated from Cuchiara et a/. 148. A low molecular weight solute 
(toluidine blue MW= 305 Oa), at all hydrogel concentrations, had similar effective diffusivities to 
that of the solute in water. Increasingly larger molecular weight solutes (3 kOa and 10 kOa 
dextran fluorescein) exhibit decreased effective diffusivity when compared to the solute's 
diffusivity in water. This behavior is indicative of steric hindrance effects between the solute and 
the PEGOA hydrogel pore network. Oiffusivity in water as a function of molecular weight was 
generated from the Stokes-Einstein equation Fournier et a/149 
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6.4.3. Determination of PEGDA Network Properties 
Sub-micron characterization of hydrogel physical structures is difficult to 
directly measure through electron microscopy techniques due to the need for 
high vacuum environments. Commonly the presence of a high vacuum has 
deleterious effects on hydrogel structures and provides an artifact laden 
representation of physical structure. Therefore much effort has focused on 
empirical swelling based models to determine the physical structure of hydrogel 
networks. The most important parameters these models generate to characterize 
hydrogel network structure are the molecular weight between crosslinks (Mc) and 
the corresponding average mesh or pore size (~). 
A model that has gained particular traction is the Flory-Rehner theory15o. 
This theory models a hydrogel that is immersed in a fluid medium at swelling 
equilibrium experiences only two thermodynamically driven forces (1) the 
entropically driven force to mix or solubilize in the immersed medium (aGmixing) 
and the elastic recoil forces of the polymer chains (aGelastic). However, the 
Iynchpin assumption of the Flory-Rehner model assumes swelling equilibrium 
with the surrounding solutions. Unfortunately, embedding PEGDA within the 
much stiffer PDMS housing invalidates this assumption and prohibits the 
application of this model to the PDMS/PEGDA microfluidic hydrogel. Due to the 
lack of adequate models describing network structure in swelling restricted 
hydrogel systems and in order to justify our conclusion that a decrease in 
PEGDA effective diffusivity occurs with increasing polymer concentration we 
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have employed a logic based explanation of how PEGDA pore size and 
diffusivity decrease with an increase in PEGDA concentration (Figure 39). 
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Figure 39: Volume Filling Logic Based Explanation for Polymer Concentration Effects on Diffusivity 
in Swelling Restricted Systems. 
In brief we are suggesting that the system is of a fixed volume across all 
hydrogel concentration experiments. This volume can then be filled with various 
concentrations or volumes of PEGDA polymer. In one extreme case there is no 
polymer, the area available for solute diffusion is not limited and the effective 
diffusivity of the solute is the same as that in water (Figure 39A.). As small 
amounts of polymer begin to fill the fixed volume (Figure 39B) the volume is now 
occupied in part by water and in part by polymer. With the polymer void fraction 
being the only space available for diffusion. The solute effective diffusivity in this 
system is a fraction of value in water due to the reduced area available for 
diffusion or the reduced average pore size. As more polymer begins to fill the 
same fixed volume (increasing concentration; Figure 39C), the polymer void 
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fraction, the area available for diffusion and subsequently the average pore size 
decreases. This can be also seen as a decrease in effective diffusivity and we 
believe is the most likely mechanism explaining the mass transport changes 
observed in our system. 
6.4.4. Spatiotemporal Cell Viability Gradients 
Optimization of nutrient and waste gradients through rational microfluidic 
network design provides a tool to maintain cell viability and increase overall 
scaffold metabolic denSity. Viability of encapsulated 3T3 fibroblasts was shown 
to vary as a function of culture time, distance from perfused channel, and static 
vs. perfused culture (Figure 40 & Figure 41). A trend of decreasing cell viability 
with increasing distance from the microchannel wall was observed between 24-
72 hrs of culture (Figure 40 & Figure 41). Regions closest to the channel (0-600 
IJm) were shown to have significantly higher cellular viability than the external 
regions (600-1500 IJm) at both 48 and 72 hr of culture (paired t-test, n=3, p < 
0.05). This trend was not observed at early time points and only became 
pronounced later in the culture (Figure 40 & Figure 41). 
Necrotic region (cell viability < 30%) size as well as the overall system 
viability was improved in perfused systems when compared to static controls 
(Figure 41). 3T3 fibroblast viability in perfused systems was significantly higher 
compared to static controls at all time points greater than zero for distances 
between 0-900 IJm from the microchannel wall (paired t-test, n=3, p < 0.05) 
(Figure 41). Necrotic regions in static systems, at late timepoints (t = 72 hr), were 
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shown to occur throughout the entire thickness of the scaffold while necrotic 
cores in perfused systems were confined to the regions of the scaffold farthest 
from the nutrient source. (distances> 600 ~m) (Figure 41). Increased cell viability 
in perfused systems was attributed to convection-driven renewal of nutrient 
concentration gradients that are otherwise depleted over time in static systems. 
Furthermore, removal of waste products that otherwise build up in static systems 
was thought to also positively affect cell viability. 
A c 
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Figure 40: Encapsulated 3T3 fibroblast spatiotemporal cell viability fluorescent 
micrographs. (A) Isometric schematic of PDMS/PEGDA microchannel device with dashed line 
indicating location of cross section shown in panel 8, (8) Cross section schematic of 
PDMS/PEGDA microchannel device indicating the size and location of the confocal z-stacks 
relative to the perfused channel, (C) Live/Dead (Calcein AM/Ethidium Homodimer) confocal 
fluorescent micrographs (20x, 318 x 318 mm FOV) of 3T3 fibroblasts encapsulated in 10% (w/v) 
6 kDa PEGDA hydrogels as a function of distance from perfused microchannel (0-1500 IJm) and 
culture time (0-72 h). At early time points (t=O and 24 h), cell viability is high and homogenous at 
distances between 0 and 1500 IJm from the channel. At later time points (t=48 and 72 h), a 
distinct necrotic core (viability <30%) forms at distances greater than 600 IJm from the perfused 
channel. Recreated from Cuchiara et al. 148 
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Spatiotemporal cellular viability profiles closely reflected conclusions 
derived from models which assume that cells act as metabolic sinks with intrinsic 
properties such as metabolic consumption rate and extrinsic factors such as cell 
seeding density62,151,152. These assumptions allowed cell laden hydrogel scaffold 
systems to be modeled as having an initial average metabolic density defined as 
the product of cellular metabolic consumption rate and cell seeding density. 
However, when scaffold metabolic densities exceeded the rate at which critical 
solutes are delivered to the system, inadequate nutrient and cytotoxiC waste 
gradients develop and ce"ular elements become quiescent and or apoptose. This 
results in metabolic density profiles that para"el cell viability and ultimately 
generates a construct with reduced overall metabolic density. In order to 
maximize scaffold metabolic density, careful attention must be paid to design 
mass transport regimes that minimize necrotic regions and conserve the 
regenerative potential of the construct. 
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Figure 41: Encapsulated 3T3 fibroblast spatiotemporal perfused and static cell viability. 
Ratio of live positive cells (Calcein AM) to total cells (Calcein AM + Ethidium Homodimer) as a 
function of perfusion time (0-72 h), distance from perfused microchannel (0-1500 I-lm) and 
perfused (solid bar) vs. static (hash bar) culture conditions. Perfused viability was shown to be 
significantly less in the outermost regions (900-1500 I-lm) at 48 and 72 h of culture when 
compared to the inner regions as indicated by (*). Perfused cell viability was shown to be 
significantly higher (paired t-test, p < 0.05) than static cultures at the inner most regions (0-900 
I-lm) at all time points greater than 0 h as indicated by (+). Recreated from Cuchiara et 81. 148 
6.4.5. Applicability of Krogh Tissue Models 
Often when analyzing mass transport to a tissue bed, especially with 
respect to the affects of oxygen concentration on cell viability, a Krogh tissue 
cylinder model is applied. Krogh based models assume that solute concentration 
(C) in a bed of capillaries in a tissue can be represented as a series of cylindrical 
layers of tissue at radial distances (r) and axial distance (z) from the capillary with 
an average porosity (£gel), intrinsic effective diffusivity of the tissue space (Dgel ) 
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and a metabolic consumption rate governed by Michaelis-Menton kinetics that 
can be simplified to a maximum or average metabolic consumption rate (rmet). 
(Equation 
gel 8egel _ [.!.~( 8e ge/ ] 8 2e ge/ ]_ £ - D gel r + 2 r mel 8t r8r 8r 8z 
Equation 6: Krogh Tissue Cylinder Model 
Although this is a very useful model, it assumes that the resonance time 
for blood in the capillaries is on the same order as the tissue effective diffusivity 
and therefore axial variation of solute concentration (z) in the capillary is 
impressed upon the tissue space. We have specifically engineered our 
microchannel flow regimes such that flow rate, which is related to resonance 
time, is much greater than the rate of diffusion into the tissue space (see 
Equation 3, high Peclet Number1400-4300). This operating parameter allows us 
to neglect axial changes in concentration and simplifies the Krogh tissue model 
to a non-steady state 1 D-diffusion equation with a metabolic sink or consumption 
term that is a function of cell type (c) and cell seeding density (p). 
Equation 7: Simplified Krogh Tissue Cylinder Model 
6.5. Conclusions 
In summary we have demonstrated a novel multilayer softlithographic 
fabrication scheme in which PDMS and PEGDA were serially replica molded to 
form enclosed perfusable microfluidic hydrogel networks. Furthermore, we 
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demonstrated the ability control spatiotemporal solute diffusion profiles by 
varying hydrogel concentration and solute molecular weight. Interestingly, 
varying PEGDA concentration had a minimal effect on toluidine blue (MW= 305 
Da) effective diffusivity at all PEGDA hydrogel concentrations with values similar 
to that of the solute in water alone. However, higher molecular weight solutes to 
(3 kDa and 10 kDa dextran fluorescein) had a dramatic effect on effective 
diffusivity. The effective diffusivity of 3 kDa and 10 kDa dextran fluorescein 
decreased to 5.3% and 0.11 % of their values in water respectively. This reduced 
transport of dextran through the PEGDA hydrogel matrix was thought to be 
primarily due to sterically hindered diffusion of dextran through the PEGDA pore 
structure. Spatiotemporal modulation of nutrient and signaling gradients provides 
a mechanism to control cellular phenotype and differentiation state as a function 
of distance from the perfused microchannel. This tool has the potential to provide 
much needed insight into soluble factor control over cell phenotype and can be 
implemented to direct tissue pattern formation within in vitro culture systems. 
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Figure 42: Schematic Demonstrating Effects of Optimal Microchannel Network Spacing on 
Oxygen Gradients and Cell Viability Profiles. (Left) Oxygen levels and cell viability decreases 
as distance from the microchannel or number of cell layers increases until oxygen levels reach 
necrotic levels (white; gradient bar). (Right) Optimal spacing of microfluidic networks maintains 
oxygen concentration at adequate levels to support cell viability across. 
Our observations support that perfused PEGDA microfluidic hydrogel 
systems have higher cellular viability and subsequently enhanced metabolic 
density over static culture systems. Detailed understanding of metabolic 
gradients as a function of cell type and seeding density provides useful rational 
design parameters, such as channel spacing, that allows for maximization of 
cellular viability and scaffold metabolic density. For example, a channel spacing 
of 600 ~m for 3T3 cultures seeded at 11 x 106 cells/mL would lead to greater 
than 60% average construct viability which is nearly a six fold increase over the 
static system (Figure 40 & Figure 41). This work provides an important tool set to 
reduce transport limitations in tissue engineering constructs and promote the 
formation of robust and complex tissues in vitro. 
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7. Chapter 7: Perfused Microchannel Integration with 
Microvascular Networks 
7.1. Introduction 
Despite significant progress, clinically viable regenerative medicine-based 
therapeutics are restricted to thin and metabolically diffuse systems limited by the 
lack of perfused vascualuture. 59,153,154 Vascularization approaches that rely solely 
on implant anastomosis with the host are limited by slow host vessel ingrowth 
(tenths of micrometers/day61) and non-homogenous vessel distribution within the 
construct155. Often these insufficient transport regimes result in a necrotic core 
and a reduction in the construct's overall therapeutic potential. 62 
Engineering of microvascular networks in vitro prior to implantation, known 
as pre-vascularization, holds the promise to improve slow and insufficient host-
implant anastomosis. 102 Despite pre-vascularization progress in natural and 
synthetic biomaterials, 95,156 microvascular network perfusion in vitro has 
remained absent from the literature. Perfusion of self-assembled microvascular 
networks through lumen supported convective transport followed by extra vessel 
diffusion holds the promise to recapitulate favorable biomimetic mass transport 
regimes in vitro and improve host-implant integration.157 Perhaps more important 
and markedly absent from the pre-vascularization literature is self-assembled 
microvascular network integration with microfabricated channels. Fabricated 
microchannel integration with self-assembled microvascular networks allows for 
controlled convective transport to occur across large length scales in a wide 
range of vessel diameters and would result in improved anastomotic interfaces. 
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Herein we report the integration of multilayer microfluidic 
polydimethylsiloxane- polyethylene glycol (PDMS-PEG) hydrogel microdevice 
with a self-assembling pro-vasculogenic co-culture of human umbilical vein 
endothelial cells (HUVECs) and pericyte precursors (10T %). We demonstrate 
that the device can be used to spatiotemporally control microvascular network 
self-assembly and system apoptotic activity. In addition, integration of self-
assembled microvascular networks with microfabricated channels shifted the 
construct's transport regime to vessel supported convective transport followed by 
extra vessel diffusion. This work has direct implications towards the development 
of perfusable pre-vascularized tissues in vitro for cell culture and regenerative 
medicine applications. 
7.2. Objectives 
• Demonstrate and characterize microvascular network self-assembly within 
PDMS/PEG microfluidic device 
• Integrate self-assembled microvascular networks with fabricated channel 
• Perfuse self-assembled microvascular networks from fabricated channel 
• Evaluate changes in transport between non-vascularized and vascularized 
system 
7.3. Materials and Methods 
7.3.1. Cell Maintenance 
Human umbilical vein endothelial cells (HUVECs) (Lonza , Walkersville, 
MD) were grown in endothelial growth medium (EGM-2, Lonza , Walkersville, 
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MD) supplemented with 2mM L-glutamine, 1000 U mL-1 penicillin, and 100 mg L-1 
streptomyocin (Sigma-Aldrich, St. Louis, MO) and used between passages 3-8. 
10T % cells (American Type Culture Collection, Rockville, MD) were grown and 
maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 
10% fetal bovine serum (FBS), 2mM L-glutamine, 1000 U mL-1 penicillin, and 100 
mg L-1 streptomyocin (Sigma-Aldrich, St. Louis, MO) and used at passages 16-
20. All cells were incubated at 3r C in a 5% CO2 environment. 
7.3.2. Proteolytically Degradable PEG Pre-Polymer Synthesis 
Extracellular matrix (ECM) derived peptide sequences have been shown 
to be specifically cleaved by matrix metalloproteases (MMP). 158 Conjugation of 
the collagen ECM mimetic peptide sequence (GGPQGIWGQGK) to non-
proteolytically degradable synthetic polymers has been shown to result in 
complete degradation of the polymer network by specific MMPs and other broad 
acting proteases.43 Furthermore, the conjugation of the GGPQGIWGQGK 
sequence to monoacrylate terminated photocrosslinkable PEG macromers in an 
ABA block co-polymer system has demonstrated the ability to promote polymer 
construct remodeling and support microvascular network formation by HUVECs 
and 10T % co-cultures.43 
The peptide sequence GGPQGIWGQGK was synthesized by standard 
solid phase FMOC chemistry using an Apex396 peptide synthesizer (Aapptec; 
Louisville, KY). Following synthesis and purification, the peptide product was 
verified using matrix-assisted laser desorption ionization time of flight mass 
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spectrometry (MALDI-ToF; Bruker Daltonics, Billerica, MA). (see Appendix for 
MALDI - ToF results) A diacrylate terminated ABA block co-polymer of the 
peptide sequence was synthesized by reacting heterobifunctional acrylate-PEG-
N-hydroxysuccinimide (Laysan; acrylate-PEG-NHS, 3400 Da) in a 1 :2.2 
(peptide:PEG) molar ratio in anhydrous dimethylsulfoxide (DMSO, Sigma-Aldrich, 
St. Louis, MO) in the presence of 15 mM N,N-Diisopropylethylamine (DIPEA, 
Sigma-Aldrich, St. Louis, MO) overnight. (Figure 43) This reaction conjugates a 
PEG monoacrylate to the amine terminus of the peptide sequence and to the 
lysine's amine side chain at the peptide's carboxy terminus using standard N-
hydroxysuccinimide amine chemistry. The resulting product's reaction volume 
was slowly diluted 2: 1 in an ice bath with ultrapure H20 and dialyzed (5000 
MWCO regenerated cellulose, Spectrum Laboratories, Rancho Dominguez, CA) 
for 4B hrs to remove DIPEA, DMSO, and un-reacted PEG and peptide moieties. 
The product was then frozen at -BODC, lyophilized for 72 hrs, and stored under 
argon at -BODC until further use. The cell adhesive ligand Arg-Gly-Asp-Ser, 
(RGDS, American Peptide Sunnyvale, CA) was conjugated to acrylate-PEG- N-
hydroxysuccinimide in a 1 :1.1 (PEG:RGDS) molar ratio under the same 
conditions as the PEG-Peptide-PEG block co-polymer.(Figure 43) (see Appendix 
for bioconjugate characterization) 
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Figure 43: Reaction Schematic of Peptides with Heterobifunctional PEG linkers to form 
tethered adhesion peptides and a proteolytically degradable PEG derivative. (A) The amino 
acid sequence RGDS is reacted with acryoyl-PEG-N-hydroxysuccinimide. (8) A collagen derived 
ECM mimetic peptide sequence (GGPQGIWGQGK) was reacted in a 1:2 molar ratio with acryoyl-
PEG-N-hydroxysuccinimide to form a degradable peptide sequence flanked by acrylate 
terminated PEG chains. 
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7.3.3. Multilayer Photolithographic Fabrication of Perfused PEG Scaffold 
A po~ ~
 • 2.5% P G-PQ-P G 
• 2 mM P G-RGOS 
• 4:1 HUVEC:10T ~ 
• 30X106 c IIslmL 
B 
Figure 44: System Design Schematic and Microvascular Network Formation. (A) Device 
Fabrication and System Design Schematic. (B, Left) Photolithographic fabrication of PEG 
hydrogel slab in PDMS housing Transparent microfabricated PDMS housing (gray) with 
vasculogenic PEG hydrogel (cyan) located between two microchannels perfused with endothelial 
growth media (red) and buffer (blue). (Middle) Schematic showing relationship of PEG hydrogel to 
perfused media and buffer microchannels and the spatial relationships of tiled imaged regions to 
the two channels. (Bottom) Representative immunohistochemistry images of the self-assembled 
microvasculature in the 0-300 IJm distance from the media microchannel. HUVECs (green; anti-
PECAM) are shown forming connected microvascular networks and 10T Y2 cells (red; anti-smooth 
muscle alpha actin) are shown acting as pericytes wrapping and stabilizing vessel networks 
(inset; arrow) (blue, DAPI). 
Poly( dimethylsiloxane) (PDMS, Sylgard 184) housings were prepared 
using standard softlithographic techniques as previously described. 148 Briefly, 
PDMS housings (15:1, silicone elastomer: curing agent) were molded to 
photoresist masters (SU-8 2100, 350 um in height, Microchem, Newton, MA) to 
create a robust housing with perfusion access ports and transparent optical 
qualities for ease of imaging ( see Figure 36). All PDMS housings were treated 
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with the photoinitiator acetophenone (2,2-dimethoxy-2-phenyl acetophenone in n-
vinylpyrrolidone, 300 mg mL-1, Sigma) for 5 min to promote free radical induced 
interfacial polymerization of the acrylate terminated PEG pre-polymer solution to 
the POMS housing. Excess photoinitiator was removed via sequential rinsing 
with 100% ethanol and ultrapure H20 and dried with filtered air. Acetophenone 
coated POMS housings were sealed to glass slides treated with SigmaCote 
(Sigma-Aldrich, St. Louis, MO) aligned and overlaid with a transparency 
photomask (20,000 dpi, CAO/ART Services, Bandon, OR) to control spatial 
photopolymerization and hydrogel geometry within the POMS housing. (Figure 
44) 
The MMP degradable PEG block copolymer and PEG-RGOS were 
dissolved in EGM-2 to final concentrations of 2.5% (w/v) and 2 mM respectively. 
The photoinitiator Irgracure-2959 (Ciba, 100 mg mL- 1 in 200 proof ethanol) was 
added to the pre-polymer solution at 30 IJL mL-1. HUVECs and 10T % cells were 
suspended in the pre-polymer solution in a 4:1 ratio (HUVEC:10T % ) to a final 
concentration of 30x1 06 cell mL-1 . The resulting cell-pre-polymer solution was 
injected into the POMS housing through the perfusion access ports and exposed 
through the photomask to long wavelength UV light (365 nm, 10 mW cm2-1) for 5 
min to crosslink and fabricate the PEG hydrogel structures. The POMS housing 
with the embedded photocrosslinked PEG hydrogel was gently rinsed with sterile 
phosphate buffered saline (PBS, pH 7.4), dried with canned air and sealed to #1 
cover glass. The cell-hydrogel construct was perfused at 600 IJL hr -1 with EGM-2 
at one interface and sterile PBS on the opposite interface to establish a gradient 
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of growth factors, nutrients, and waste species across the construct (Media-
Buffer configuration). (Figure 44) Some experiments were conducted in a Media-
Media configuration where both hydrogel construct channel wall interfaces were 
perfused with EGM-2 in order to determine the maximum distance microvascular 
networks would develop form the perfused microchannel. 
7.3.4. Immunohistochemistry Staining 
Immunofluorescence staining was performed to determine spatiotemporal 
microvascular network characteristics and the cell-cell relationships within the co-
culture. At 0, 48 and 96 hr perfusion was terminated and hydrogel microdevices 
were fixed, permeabilized and stained with primary and secondary antibodies 
(Figure 45). The primary antibodies used were mouse anti-SM a-actin (Sigma-
Aldrich, St. Louis, MO) to label the 10T % cells and goat anti-PECAM (Santa 
Cruz Biotechnology, Santa Cruz, CA) to label the membranes of HUVECs. The 
secondary antibodies used were anti-mouse and anti-goat conjugated with either 
Alexa flour 488, Alexa flour 532, and or Alexa flour 647. DAPI (300 
nM,lnvitrogen) was used as a nuclei counter stain for all immunofluorescence 
images. 
7.3.5. Spatiotemporal Microvascular Network Morphology Analysis 
Spatiotemporal PECAM immunofluorescence images were analyzed at 0, 
48 and 96 hr post device fabrication to determine the effects of perfusion time 
and distance from the EGM-2 perfused microchannel on microvascular network 
morphology (Figure 46). The PECAM immunofluorescence was imaged using a 
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confocal microscope (Zeiss LSM 5 Live, 20xlNA 0.8 objective, FOV 318x3181Jm, 
vertical z-stack: 1 IJm slices, 50 slices per region, Carl Zeiss Inc., Thornwood, 
NY). Regions were tiled at 300 IJm intervals radially outward from the perfused 
media microchannel wall to the PBS microchannel wall for a total of 10 regions 
spanning the 3 mm thickness of the hydrogel construct. 
Pre-processing of the LSM images was accomplished by first applying a 
maximum intensity projection to the z-stack using the image browser function in 
the LSM Image Examiner software (Carl Zeiss Inc., Thornwood, NY). After 
maximum intensity projection, channe'ls were split and the PECAM 
immunofluorescence channel was thresholded to preserve the tubule elements, 
while decreasing the background signal. The resulting thresholded image was 
then used to measure the lengths of the tubule elements within the construct. 
Each tubule was measured manually using the image browser measurement 
tool, where single tubules were determined as starting at one branch and ending 
at another. Both the tubule lengths and the total number of tubules were 
recorded for each representative image at different locations within the 
constructs. 
7.3.6. Spatiotemporal TUNEL Apoptosis Assay 
Spatiotemporal apoptotic profiles at 48 and 96 hr of culture were analyzed 
using the Click-It TUNEL assay for DNA fragmentation (Invitrogen, Carlsbad, 
CA). Samples were fixed, permeabilized and labeled with the manufacture 
recommended protocols and counterstained wit DAPI (300 nM,lnvitrogen). 
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Fragmented DNA fluorescence was imaged using a confocal microscope (Zeiss 
LSM 5 Live, 20xlNA 0.8 objective, FOV 318x3181Jm, vertical z-stack: 1 IJm 
slices, 50 slices per region, Carl Zeiss Inc., Thornwood, NY). Image regions were 
tiled at 300 IJm intervals radially outward from the perfused media microchannel 
wall to the PBS microchannel wall for a total of 10 regions spanning the 3 mm 
thickness of the hydrogel construct. At each region and time point, the ratio of 
apoptotic cells (TUNEL positive) to total cells (DAPI positive) was analyzed and 
plotted to indicate percentage of apoptotic cells. Control samples treated with 
70% ethanol were used to set the TUNEL positive imaging parameter values and 
to avoid false positive TUNEL signal. (Figure 47) 
7.3.7. Analysis of Acellular and Vascularized Mass Transport 
System mass transport properties were analyzed in acellular PEG 
hydrogel constructs and the vascularized constructs after 96 h of culture. High 
molecular weight fluorescent dextran (dextran- FITC, lysine fixable, 2 x106 Da; 
Invitrogen, Carlsbad, CA) was added to the perfusion media and flow was set at 
600 IJL hr 1. Images of the region immediately adjacent to the microchannel wall 
were collected for 120 min via time lapse live-cell fluorescent confocal 
microscopy (Figure 48 A,B & C) (Zeiss LSM 5 Live, 20xlNA 0.8 objective, FOV 
318x318 IJm, vertical z-stack: 10 IJm slices, 6 slices per region, Carl Zeiss Inc., 
Thornwood, NY). In some vascularized constructs, post time lapse imaging, the 
dextran was fixed using 4% paraformaldehyde and vessel structures were 
stained using anti-PECAM and DAPI to determine the spatial localization of 
dextran relative to vessel structures. (Figure 480) 
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The rate of dextran transport in the acellular and vascularized systems 
was assessed by measuring the total fluorescence signal in regions 10, 50 and 
80 IJm from the channel wall over time using the Image Processing Toolbox in 
MatLab. (Figure 49) The difference in vascularized and acellular dextran 
accumulation (% Convective Transport) was determined by taking the difference 
of vascularized and acellular values at a time point and plotting as a percentage 
of the vascularized value.(see Equation 8) Differences in the dextran fluorescent 
intensity landscape of the acellular and vascularized images were assessed 
using the Plot Profile function in Image J. Raw intensity value were normalized to 
maximum intensity in order spatially overlay the data. To evaluate extra vessel 
diffusion, changes in vascularized intensity peak widths and peak aspect ratios 
(aspect ratio = peak height/peak width) were measured over time at a constant 
intensity value. 
0/ C . Tl Vascularized Intensityt - Acellular Intensityt 100 
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Equation 8: Equation for Calculation of % Convection Transport Trace 
7.4. Results and Discussion 
7.4.1. Multilayer PDMS/PEG Micro Device Characteristics and Advantages 
PEG hydrogel incorporation within a robust PDMS housing addresses a 
number of the logistical. challenges associated with handling microfluidic 
hydrogels and negates the need for complicated supporting apparatuses. 130 In 
addition, PDMS fluid access ports allow for transient and precise control over 
vascular bed concentration and pressure gradients while maintaining the 
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hydrogel in a sterile and non-dehydrating environment. Furthermore, this 
multilayer approach results in independent control over PDMS housing and PEG 
hydrogel geometry allowing for freeform user defined fabrication of tissue-
mimetic PEG hydrogel structures within the PDMS housing. (Figure 44) A 
particularly advantageous characteristic of this microfabricated system is the 
ability to localize perfusion interfaces in close spatial proximity to self-assembled 
vessel networks within the hydrogel bulk. This allows for study of interfacial mass 
transport from fabricated channels 1 mm in diameter to microvascular networks 
30 IJm in diameter and enables integrated transport across large length scales 
(Figure 45). 
7.4.2. Spatiotemporal control of co-culture self-assembly 
Our group and others have previously shown that media perfused 
microfluidic channels within tissue engineered constructs can improve system 
mass transport properties and increase overall cell viability. Despite this 
technological advancement, cell viability and metabolic density decrease as a 
function of distance from the media perfused microchannel. 14, 15 Network design 
with reduced distances between microchannels has been shown to counteract 
necrosis and increase overall construct viability.13o However, current hydrogel 
microfabrication technologies limit microchannel network complexity to 2D planar 
designs.131 Formation and perfusion of 3D self-assembled microvascular 
networks between fabricated microchannels shifts the characteristic diffusion 
length from fabricated channel spacing to the much shorter distance between 
vessels controlled by microvascular network density. Therefore it is important to 
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determine the microfabricated channel spacing that supports microvascular 
network self-assembly and therefore minimizes overall system diffusion lengths. 
Here we set out to determine the maximum distance, from a perfused 
media channel, that supports microvascular network self-assembly in the pro-
vasculogenic PEG hydrogel. For this study, perfused microchannel systems were 
either configured in a Media-Buffer configuration analogous to capillary-lymphatic 
mass exchange or a Media-Media configuration analogous to inter-capillary 
exchange (Figure 44) Spatiotemporal microvascular network self-assembly was 
evaluated by anti-PECAM immunohistochemistry labeling of HUVEC membranes 
followed by morphological analysis of total tubule length and number (see 
Materials & Methods Immunohistochemistry Staining) 
Microvascular network formation in the Media-Buffer configuration was 
highly dependent upon culture time and distance from the perfused media 
microchannel. A trend of decreasing total tubule length and total tubule number 
with increasing distance from the media microchannel was observed at both 48 
and 96 h of culture. (Figure 45 & Figure 46) Both total tubule length and total 
tubule number at 96 h were significantly greater in the nutrient rich regions « 600 
IJm from the media microchannel) when compared to all regions greater than 600 
IJm. (p<0.05, n=3,Figure 46) However, this trend was not present at early time 
pOints in microvascular network formation where cellular coalescence and self-
assembly was relatively homogenous and did not vary Significantly with distance 
from the media microchannel (Figure 45 & Figure 46; t= 48 h). Moreover, only 
microvascular networks within the region closest to the media microchannel (0-
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300 ~m from microchannel) experienced significant increases in total tubule 
number and length from 48 to 96 h (p<0.05, n=3, Figure 45 & Figure 46) while 
microvascular networks within the constructs interior regions (900-21 00 ~m from 
microchannel) experienced a significant decrease in total tubule number and 
length over the same time period (p<0.05, n=3, Figure 45 & Figure 46). 
A 
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Figure 45: Spatiotemporal Microvascular Morphology. (A) Immunohistochemistry fluorescent 
micrographs of HUVECs (green; anti-PECAM) 10T % (red; anti-smooth muscle alpha actin) and 
DAPI (blue) as a function of culture time (0, 48, & 96 h ) and distance (300 IJm regions; 0-3000 
IJm) from the perfused media microchannel. Tubules start as homogenously seeded 3D co-
culture suspensions at time 0 h and self organize to form tubules over 96 h. Interestingly at 48 h 
of culture initial tubule coalescence persist into the interior regions of the scaffold but by 96 h only 
the nutrient rich regions (0-600lJm) support tubule formation. (8) Enlarged images of the 0-300 
(left) 1200-1500 (center) and 2700-3000 IJm (right) regions at 96 h. 
The Media-Media configuration encouraged microvascular network 
formation at greater distances from the microchannel than the Media-Buffer 
configuration displaying high levels of self-assembly throughout the entire 
thickness of the construct at 96 h of culture (Figure 46; hashed bars). Perhaps 
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the most interesting characteristic of the Media-Media configuration is its ability to 
support robust microvascular network growth from 48-96 h. In the Media-Media 
configuration all regions experienced increases in tubule length and number from 
48-96 h whereas in the Media-Buffer system this increase was only observed 
within the nutrient rich regions less than 300 J.Jm from the perfused microchannel. 
o ceframC 
Figure 46: Spatiotemporal Self-Assembled Microvascular Network Morphology. Total tubule 
number (A) and total tubule length (B) in a Media-Buffer configuration (solid bars) and a Media-
Media configuration (hashed bars) as a function of distance from the microchannel (0-3000 ~m) 
and perfusion time 48 (red) and 96 h (green). Robust microvascular network formation (total 
tubule length and number) in the Media-Buffer system was confined to regions closest to the 
media microchannel (0-600 ~m) with the interior regions (1200-2100 ~m) not forming networks at 
96 h. Interestingly the Media-Media configuration maintained microvascular network formation 
farther from the microchannel but with an overall lower number of total tubules and a decrease in 
total tubule length at each time and location when compared to the Media-Buffer configuration . 
(p<0.05, n=3, paired t-test, (+) indicates 48 h vs. 96 h temporal significance, (*)indicates spatial 
significance compared to the 0- 300 ~m region, and :t: indicates Significance between Media-
Media and Media-Buffer at 96 h. 
7.4.3. Spatiotemporal Construct Apoptotic Activity 
The lack of robust microvascular network self-assembly in regions farthest 
from the perfused media microchannel in the Media-Buffer configuration was 
thought to be due to necrosis driven by nutrient deprivation. To confirm that 
necrotic activity was the underlying mechanism for inhibited microvascular 
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network formation, a spatiotemporal TUNEL assay to quantify fragmented DNA 
and characterize late stage apoptotic activity was applied to the Media-Buffer 
system at 48 and 96 h of culture. The spatiotemporal apoptotic activity of the 
construct, as indicated by the fraction of TUNEL positive cells, was shown to be 
inversely related to microvascular network self-assembly. At 96 h of culture, the 
region nearest the media microchannel (Figure 48 A & B; 0-300 IJm) had 
significantly lower fraction of TUNEL positive cells than nearly all other regions 
(p<0.05, n=3, Figure 48A). Furthermore the TUNEL positive fraction was shown 
to increase from 48 to 96 h in the same regions that total tubule length and 
number were shown to decrease. Interestingly the nutrient rich region (0-300 IJm 
from channel) that experienced increases in total tubule number and length from 
48 to 96 h also exhibited low but significant increases in apoptotic activity over 
the same time period (p <0.05, n=3, Figure 48A; 0-300 IJm). This is thought to be 
due to cellular pruning that is characteristic of maturing microvascular networks. 66 
These observations taken together are suggestive of initially high and 
homogenous self-assembly into a nascent capillary plexus from 0-48 h, followed 
by network maturation in the nutrient rich regions and network regression in 
necrotic regions from 48-96 h. Spatiotemporal control over microvascular 
network formation provides a valuable design parameter to optimize 
microvascular network self-assembly and by extension, minimize construct 
characteristic diffusion lengths. 
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Figure 47: Spatiotemporal Scaffold Apoptotic Activity. (A) Spatiotemporal fraction of TUNEL 
positive cells normalized to DAPI. (8) Spatiotemporal fluorescent micrographs of TUNEL positive 
cells. Spatiotemporal construct apoptotic signal normalized to in the Media-buffer configuration. 
TUNEL signal increased with increasing distance from the media microchannel with interior 
regions (1500-1800 jJm) showing the highest level of apoptotic activity at 96 h. (n=3, paired t-test, 
p<0.05, + indicates 48 vs. 96 h temporal significance at a given distance * indicates 96 h spatial 
significance compared to 0-300 jJm) 
7.4.4. Functional Convective Vessel Transport and Shifting Transport 
Regimes 
Non-vascularized hydrogel mass transport regimes are limited to passive 
diffusion governed by the system concentration gradients and the effective 
diffusivity relationship of the solute and hydrogel matrix.21 Diffusional distances in 
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these constructs are defined by the overall size of the construct or in the case of 
microfluidic hydrogel systems, the distance between channels. Transport within 
vascularized constructs is characterized by rapid, lumen-supported convection 
through the microvascular network followed by diffusion out of the vessel 
structures. 159 In addition, the characteristic diffusion length in vascularized 
systems is not the overall construct geometry, but the distance between vessels. 
Therefore transport in vascularized systems is much more efficient than a purely 
diffusional system because convection is used to transport mass across large 
distances while diffusion is only required to drive transport the short distance 
between vessels. Recapitulation of this transport regime within an in vitro 
construct is advantageous for the development of more robust tissue culture 
systems that can produce bulkier, more clinically relevant tissue-engineered 
therapeutics. 
Here we set out to compare the mass transport characteristics of a non-
vascularized, acellular hydrogel with a vascularized hydrogel containing the self-
assembled microvascular networks. Pro-vasculogenic PEG hydrogels containing 
the high-density co-culture of HUVEC and 10T % cells were cultured in the 
Media-Media configuration for 96 h to drive microvascular network self-assembly. 
After 96 h of culture, growth medium was supplemented with high molecular 
weight fluorescent dextran (2 x1 06 Da) and time-lapse confocal microscopy was 
used to image dextran transport through the construct for 180 minutes at regular 
intervals. In a separate study, non-vascularized microfabricated constructs 
containing the same pro-vasculogenic PEG hydrogel but without cells were 
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perfused with dextran and imaged using time-lapse confocal microscopy. The 
diffusion rate and the spatiotemporal intensity landscape were analyzed and 
compared between the non-vascularized and vascularized system. 
Non-vascularized hydrogels exhibited a uniformly advancing dextran 
intensity front characteristic of 1 D Non-Steady State Fickian diffusion of a solute 
through a hydrogel matrix129,148,16o (Figure 49A & Figure 50 and Figure 51A). 
Vascularized hydrogels displayed rapid, convective-like dextran transport in 
regions spatially coinciding with vessel structures (Figure 49B & C,Figure 50, 
Figure 51A). At each time point, fluorescent dextran can be seen at greater 
distances from the perfused channel in the vascularized construct when 
compared to the non-vascularized construct. (Figure 49 and Figure 50) 
Moreover, at a fixed distance from the channel, the rate of dextran accumulation 
in the vascularized system was significantly higher than the acellular system for 
the first 30 minutes of perfusion. (p< 0.05, n=9, Figure 50) Interestingly, this 
difference in vascularized and non-vascularized transport (Figure 50, % 
Convective Transport, blue trace) is greatest at early time points when 
convection is dominant and decreases over time as system transport becomes 
diffusion limited. These observations suggest that the vascularized system 
supports enhanced transport characterized by combination of convection and 
diffusion. 
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Figure 48: Mass Transport Regimes in Acellular and Vascularized PEG Scaffolds. (A) Time-
lapse intensity maps of regions directly adjacent to the microchannel wall of high molecular 
weight dextran diffusion through acellular PEG scaffolds. Acellular transport profiles behave 
according to Fickian diffusion through a polymer matrix. (8) Time-lapse intensity maps of regions 
directly adjacent to the microchannel wall of high molecular weight dextran transport in 
vascularized scaffolds at 96 h of culture. Rapid convective like transport through the matrix in 
regions coinciding with vessel structures suggests a shift in transport from purely diffusional 
transport to convection through vessel structures. (C) Enlarged high molecular weight dextran 
intensity map at 120 h post perfusion. Dotted arrows indicating newly perfused vessels, dashed 
and solid arrows indicate progressively broadened intensity profiles suggesting diffusion out of 
vessels. (0) Orthogonal projection of fixed high molecular weight dextran (red) and anti-PECAM 
IHC (green) in vascularized scaffolds at 96 h of culture. Co-localization of dextran with PECAM 
suggests transport via vessel structures. 
The dextran fluorescent intensity landscape or spatial dextran distribution 
in the vascularized system displayed rapid intensity increases occurring ahead of 
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the diffusion front which is indicative of convective, vessel-supported transport. 
(Figure 49c arrows and Figure 50A) This suggests a shift in transport regimes 
from entropically driven Fickian diffusion to rapid lumen supported convection 
through the vessel networks. To further validate that microvascular lumens 
supported convective transport, dextran perfused vascularized constructs were 
fixed and stained with anti-PECAM to determine the spatial proximity of perfused 
dextran relative to vessel lumens. Confocal imaging of the fixed dextran-perfused 
microvascular hydrogels show the dextran predominantly co-localized within the 
lumen of the microvascular structures. (Figure 480) 
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Figure 49: Dextran Spatial Fluorescence Intensity Profiles (A) Dextran fluorescence intensity 
micrographs in an acellular and vascularized hydrogel. Total dextran fluorescence accumulation 
in acellular (black trace) and vascularized hydrogels (red trace) at (8) 10, (C) 50 and (D) 80 ~m 
from the microchannel corresponding to the regions analyzed panel A. The rate of accumulation 
is greater in the vascularized system (red trace) when compared to the acellular system (black 
trace) for all distances at early time points. The difference in vascularized and acellular transport 
or the % convective transport shown as a percentage of total intensity (blue dash trace). The 
contribution of convective transport is greatest at early time points. 
In addition to supporting convective transport, vascularized constructs 
display a greatly reduced characteristic diffusion length (Av=67 IJm) when 
compared to the acellular system (Ao=3 mm). Diffusion lengths in the 
vascularized system are defined by vessel density or spacing and not overall 
construct geometry (Figure 51A). This is an important shift to a biomimetic 
transport regime where characteristic diffusion lengths are less than critical 
necrotic distances. Perhaps more significant, time lapse dextran intensity profiles 
show broadening of profile intensities and a decrease in peak intensity aspect 
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ratio over time. Together these observations suggest vascularized constructs 
support initial convective-like transport and extra vessel diffusion into the 
interstitial space. This represents an important step towards recapitulating an 
important functional mass transport property of the microvasculature. 
8 
Figure 50: High Molecular Weight Dextran Intensity Profiles and Extravessel Diffusion. (A) 
High molecular weight dextan diffusion profiles in an acellular (black trace) and vascularized (red 
trace) hydrogels. Acellular hydrogels rely on diffusional transport with construct characteristic 
diffusion lengths (AD) limited to large distances between perfused microchannels. Vascularized 
hydrogels exhibit convective transport that rapidly penetrates hundreds of micrometers into the 
hydrogel with characteristic diffusion lengths (Av) limited to the small distance between vessels. 
(8) Time-lapse (0-120 min) high molecular weight dextran intensity profiles in a vascularized 
construct show diffusion out of vessel structures as indicated by (C) increases in peak width and 
a decrease in peak aspect ratio over time. 
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7.5. Conclusions 
In conclusion, we report the integration of robust microfabrication 
technologies with a pro-vasculogenic hydrogel and co-culture that enables the 
perfusion of self-assembled microvascular networks within a multilayer 
microfluidic device. Spatiotemporal characterization of microvascular network 
self-assembly allowed for the determination of optimal microchannel spacing that 
promotes maximum microvascular network formation and minimizes necrotic 
activity. Perhaps the most significant finding for tissue engineering is the shift in 
dextran mass transport regimes from pure diffusion through a hydrogel matrix to 
microvasculature network supported convection and extra vessel diffusion. 
Combination of externally fabricated synthetic structures with self-assembled 
microvascular networks enables this shift and provides a valuable tool towards 
the recapitulation of vascular hierarchies across multiple length scales. This 
system has applicability towards the development of improved preclinical tissue 
models and more clinically relevant, pre-vascularized tissue engineered 
therapeutics. 
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8. Chapter 8: Softlithographically and 
Photolithographically Fabricated PEG Hydrogels 
8.1. Introduction 
Research activities in Chapter 7 & 8 developed technologies to build 
microfluidic networks within PEG hydrogels and demonstrated integration of 
these fabricated technologies with self-assembling microvascular networks. 
However, this research failed to address the incorporation of parenchymal 
elements within microvascular networks. (See Current Limitations in MVTE #3) 
Furthermore, previous work has failed to develop tool sets capable of fabricating 
multilayer tissue microstructures with heterogeneous cellular and matrix 
components. Therefore our recent efforts have focused on developing 
techniques to photolithographically pattern biomimetic tissue microstructures with 
heterogeneous cellular components. 
8.1.1. Multimodal fabrication strategies 
In order to fabricate multilayer heterocellular structures within PDMS 
perfusion housings, precise photolithographic alignment procedures must be 
developed. Precise multilayer alignment (tolerances < 1 mm) often requires the 
use of imaging apparatuses coupled with micromanipulators. 161 ,162 A multilayer 
alignment system applicable to hydrogel photolithography was reported by Love 
et al. 163 as a technique to achieve sub-mask limited photoresist exposures and 
an as a means to fabricate precise multilayer photoresist structures. The 
technique known as Mask Projection PhotOlithography (MPP) uses a standard 
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epifluorescent microscope with a micromanipulator stage modified to incorporate 
a photomask in an optical conjugate plane to the sample. (Figure 52) 
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Figure 51: Schematic of Microscope Modified for Mask Projection Photolithography and an 
LCD Based Exposure System. (A) Schematic demonstrating insertion of the photomask, in a 
conjugate plane to the sample stage, at the Field Stop. (8) Schematic showing the use of a 
programmable LCD as a virtual mask photocrosslinking . Recreated from Love et 8/163. and Itoga 
et 8/164 . 
This system is attractive for multilayer hydrogel photolithography due to its 
ability to align the photomask and reference structures under one wavelength of 
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light that does not initiate photocrosslinking followed by switching the light source 
and or filter set to expose the PEG hydrogel to a wavelength that drives 
photocrosslinking. This technique allows for precise, rapid, large and small 
structure fabrication and due to the prevalence of epifluorescent imaging systems 
this technique is highly amenable to the life science community. 
8.1.2. Application of Multimodal Hydrogel Fabrication to Bioartificial Livers 
(BALs) 
One of many potential tissues to mimic using multimodal heterocellular 
microfabrication strategies is the liver. Liver failure claims 70,000 lives annually in 
the U.S. and the clinical gold standard for treatment, orthotropic allograft 
transplantations, only addresses 10% of these patients. 165 These clinical 
shortcomings have driven the need for tissue engineered bioartificial livers 
(SALs). Further complicating SAL design for both extracorporeal and 
implantation applications, is a myriad of complex challenges requiring tissue 
engineers to integrate technologies across multiple disciplines. One particular 
challenging aspect is the efficient transfer of nutrients and waste from the 
metabolically dense hepatic tissue structure. Moreover, the liver is highly 
heterocellular and has a very distinct structure-function relationship 115 making it a 
tissue that requires complex fabrication schemes to recapitulate structure in vitro. 
(Figure 53) Together these factors have motivated great interest to apply and 
develop multimodal heterocellular hydrogel fabrication technologies to SAL 
design. 
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Figure 52: Schematic Diagram of Liver Functional Unit. The hepatic artery and portal vein 
deliver blood to the hepatocyte rich liver sinusoid. Hepatocytes, which make up 70-80% of the 
cytoplasmic mass, secret and store proteins, and modify or detoxify both exogenous and 
endogenous substances for excretion in the central vein. Recreated from Lee et 81. 166 
Early implantable constructs employed to restore liver function focused on 
microparticles as cell carriers 167 or encapsulation of hepatocytes in 3D polymer 
scaffolds 168,169. Unfortunately, large decreases in cell viability due to inadequate 
mass transport resulted in poor long-term functionality.17o One approach to 
address inadequate mass transport in BALs is the fabrication of microfluidic 
conduits to perfuse BALs.87 Several designs have been studied using standard 
softlithographic techniques to fabricate parenchymal and perfusion chambers 
separated by filtering membranes. 105,166 (Figure 54) One highly biomimetic 
multilayer approach employed a branched microvascular network compartment 
overlaid with a hepatocytes parenchymal compartment. 171 (Figure 54 A & B) 
Although this construct was highly biomimetic in structure, the material used to 
fabricate the device (PDMS) is not suitable for long-term implantation or tissue 
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integration and therefore these devices and similar technologies are limited 
extracorporeal applications. 
Figure 53: Microfabricated, Perfusable, Multi-compartment BAL Devices. (A) Macro view of 
perfused biomimetic microvascular networks in POMS. (B) Cross section of POMS chambers 
where the fabricated microvascular network channel, V, is separated from the hepatic 
compartment, H, by a nanoporous membrane, M. (C) Schematic showing design of a POMS BAL 
with a cell chamber (blue) and a perfusion vasculature like chamber (red) separated by an 
endothelial like barrier (gray). (0) Light microscopy image of cell chamber and endothelial cell 
barrier. (E) Calcien AM stain (green) with Hoechst nuclei counter stain (blue) indicating high cell 
viability at 7 days. Recreated from Carraro et al. 171 and Lee et al. 166 . 
A more biocompatible SAL analog fabricated from materials suitable for 
implantation and tissue integration was reported by Tsang et al. 34 in 2007. This 
device utilized multilayer photolithographic fabrication of poly(ethylene glycol) 
diacrylate (PEGDA) hydrogels encapsulated with high density cultures of primary 
hepatocytes. (Figure 55) Although this construct demonstrated functional urea 
secretion and high initial cell viability, it did not integrate any perfusion conduits to 
address transport limitations nor did it incorporate heterocultures consisting of 
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supporting cellular components known to improve liver function and drive hepatic 
tissue formation. Furthermore, PEGDA hydrogels are not degradable by cellular 
proteases or by hydrolysis at physiologic pH. Therefore implantation of this 
construct would not likely result in adequate host-implant integration. 
A 
Figure 54: Multilayer Additive Photolithographic Fabrication of PEGDA Hydrogels with 
Encapsulated Hepatocytes. (A) Schematic showing mask alignment, injection ports and 
hydrogel structure fabrication in an additive fashion. (8) Light micrograph and (C) phase contrast 
micrograph of 3D hepatic tissue analog. Recreated from Tsang et al. 34 
The previous designs address the livers complex structure by developing 
novel microfabricated devices; however they neglect the liver's heterocellular 
nature and the effect of cell-cell signaling on hepatocytes phenotype and 
function. Hepatocytes morphology and function has been shown to be modulated 
by epithelial172 and fibroblast173 co-cultures. Early studies of these co-culture 
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effects focused on 20 substrates to assay the role of cell contacts 174 and trans-
well assays to isolate the effects of soluble signals 175. More recently 
microfabrication techniques, such as microcontact printing 176 and 
photolithographic patterning 177, have been used to specifically probe the nature 
of the co-culture interaction. (Figure 56) 
Figure 55:Hepatocyte Fibroblast Microfabricated Co-Culture. (left) Hepatocyte cell islands without 
fibroblasts (middle) with fibroblasts seeded as a backfill layer at day 1 and (right) co-culture at day 5 self 
organizes with interisland contacts. Recreated from Revzin et al. 177 
However, the effect of a pro-tubulogenic co-culture (HUVECs +1 OT % see 
Chapter 5) on hepatocyte function is less understood. A very interesting synergy 
when combining this co-culture with hepatocytes is due to the pluripotency of the 
10T % mesodermal derived stem cell. It has been shown that in addition to acting 
as a vessel stabilizing pericyte75 , co-culture of 10T % with hepatocytes was 
shown to improve hepatocyte function within in vitro cultures. 178,179 Therefore this 
tri-culture system becomes a very interesting platform to improve hepatocyte 
function, and drive microvascular network formation that improves transport and 
likely in syncytium with others cell types may drive the self organization of 
hepatic tissue. 
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8.2. Objectives 
• Combine softlithographic PDMS housing and PEG microfluidic channel 
fabrication methods with the ability to photolithographically pattern 
hydrogel structures in the PDMS housing 
• Develop techniques to precisely align multiple photolithographically 
fabricated PEG structures within the PDMS perfusion housing 
• Develop liver biomimetic heterocellular tri-culture techniques to both drive 
microvascular network formation from HUVECs and 10T % while 
maintaining hepatocytes viability and function 
8.3. Materials and Methods 
8.3.1. Cell Maintenance 
Human hepatocellular liver carcinoma cell (HEP G2; ATCC) were cultured 
in Eagles Minimum Essential Medium (MEM) supplemented with 10% fetal 
bovine serum (FBS), 1000 U mL-1 penicillin, and 100 mg L-1 streptomyocin (PS) 
(Sigma-Aldrich, St. Louis, MO). 3T3 fibroblasts (ATCC) were cultured as 
previously described (see Section 6.3.1-3T3 Cell Maintenance) and used from 
passages 3-10. Human Umbilical Vein Endothelial cells (HUVEC; Lonza) were 
cultured as previously described (see Section Error! Reference source not found.-
UVEC Cell Maintenance) and seeded between passages 2-6. Human 
mesodermal stem cells (10T % cells; ATCC) were cultured as previously 
described (see Section Error! Reference source not found.-1 OT % Cell Maintenance) 
nd seeded between passages 15-20. 
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8.3.2. Modification of Microscope for Mask Projection Photolithographic 
(MPP) Methods 
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Invelted Fluorescence Microscope 
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Figure 56: MPP System Schematic. (A) Modification of a Zeiss Axiovert 200M microscope with 
a transparency photomask inserted in a conjugate plain to the sample at the field-stop. Also a 
path-deflecting mirror for two illuminators is necessary for alignment under a non-crosslin king low 
intensity halogen light source and a high intensity mercury arc lamp that drives PEG hydrogel 
photocrossl inking and structure fabrication . (8) Schematic demonstrating projection of the 
transparency photomask image to the PEGDA pre-polymer solution in the PDMS housing at the 
sample stage. 
A Zeiss Axiovert 200M inverted fluorescence microscope was modified 
with a path-deflecting mirror to toggle the aligning light source (halogen white 
light illuminator) and the photocrosslinking light source (broad band mercury arc 
lamp) for control over structure fabrication .(Figure 57) Microscope modification 
with a transparency photomask utilized a standard 15 mm 3-position filter slide to 
fix the mask at the field-stop location. 
All light sources were allowed to warm up for at least 5 minute prior usage. 
The halogen light source for structure-mask alignment was set to the lowest 
intensity value. The mercury arc lamp was set to 500/0 lamp power. Band pass 
filter sets were designed for either peak intensity in the UV range (390 nm ± 10 
nm) for use with the UV photoinitiator Irgacure 2959 or peak intensity in the white 
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light range (530 nm ± 10 nm) for eosin Y based photoinitiator systems. 
Transparency photomasks were fabricated as previously described in Section 
6.3.5.1 Fabrication of SU-8 Photoresist Masters.mPDMS housing and SU-8 
Photoresist Master Preparation for Multimodal Microfluidic Hydrogel Device 
Fabrication. 
SU-8 2100 photoresist masters for the PDMS housing and SU-8 2050 
photoresist masters for PEG microchannel fabrication were prepared as 
previously described in Section 6.3.5.1 - Fabrication of SU-8 Photoresist 
Masters. PDMS housings were prepared as previously described in Section 
6.3.5.2 - PDMS Housing Fabrication. Briefly PDMS (15:1;silicone elastomer: 
curing agent) was replica molded and cured to SU-8 2100 photoresist masters to 
fabricate PDMS housings 350 IJm in height. Perfusion access ports were bored 
with 1 mm biopsy punch and treated with acetophenone/NVP solution for 5 
minutes immediately prior to use. 
8.3.3. PEG-Pre-polymer Preparation for Proof of Concept Structure 
Fabrication 
6kDa PEGDA synthesized as previously described (see Section 6.3.2 -
Poly(ethylene glycol) diacrylate synthesis) was dissolved in phosphate buffered 
saline (PBS, pH 7.4) to yield a final pre-polymer concentration of 10% (wtlvol). 
The photoinitiator Irgacure 2959 (100mg/mL in 200 proof ethanol) was added to 
the hydrogel pre-polymer solution to yield a final concentration of 3% wtlvol. 10 
IJm fluorescent polystyrene microspheres (Invitrogen) of various spectral 
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properties were added to the hydrogel pre-polymer solution at 10 million 
spheres/mL to allow for structure visualization. 
8.3.4. PEGDA Hydrogels Fabricated using Mask Projection 
Photolithography and Soft lithography 
Acetophenone coated PDMS housings were placed on the microscope 
stage and secured using a standard microscope slide holder. The halogen 
alignment light source was then turned on and the projected mask structure was 
aligned to the desired location within the PDMS housing using the 
micromanipulator stage. The alignment light source was turned off and the PEG 
pre-polymer solution corresponding to Structure #1 was injected into the housing. 
The proper band pass filter was selected and the optical path splitter was 
switched to the mercury arc lamp to expose the sample for 5 min and 
photocrosslink the hydrogel (Figure 58; Step #3). The remaining un-crosslnked 
pre-polymer solution was rinsed from the housing by repeated flushing with 
phosphate buffered saline. The photomask for Structure #2 was aligned to the 
first set of structures using the alignment light source. The pre-polymer solution 
for Structure #2 was injected and the proper band pass filter was selected and 
the optical path splitter was switched to the mercury arc lamp to expose the 
sample for 5 min and photocrosslink the hydrogel (Figure 58; Step #4). Finally for 
fabrication of the microfluidic channel networks, the PDMS housing is aligned by 
eye with the SU-8 2050 photoresist masters. The third and final PEG pre-polymer 
solution was injected in the housing and the entire housing is exposed to 
photocrosslink the microfluidic channels (Figure 58; Step #5). The PDMS 
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housing was peeled from the microchannel mold ,sealed to coverglass, and 
connected to the perfusion apparatus. 
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Figure 57: Multilayer Photolithographic and Softlithographic Fabrication Schematic of 
PDMS/PEGDA Microdevices. Standard softlithographic fabrication methods are used to 
fabricate the PDMS housing (Step #1). Serial mask directed photopolymerization of PEGDA pre-
polymers produces hydrogel structures with various physical and biochemical content. (Steps 3 & 
4) Softlithographic replica molding of PEG hydrogels to a photoresist master produces a 
perfusable microfluidic channel to support construct transport needs. 
8.3.5. Photoinitiator Effects on Structure Formation 
The effect of photoinitiator concentration and solvent type (200 proof 
ethanol or n-vinylpyrrolidone) on the ability to fabricate PEGDA structures was 
evaluated. All PDMS housings were prepared as described in Section 6.3.5.2. 
6kDa PEGDA was dissolved in PBS at 10% wtlvol. Irgacure 2959 was dissolved 
in either ethanol or n-vinylpyrrolidone (NVP) at 100 mg ImL. Photoinitiator was 
added to the hydrogel solutions at various volumes to prepare final 
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concentrations of 0.3, 0.6, 0.9, 1.2, and 1.5% wtlvol. Samples were exposed for 
5 min at 50% lamp power and imaged immediately after exposure to determine 
structure fabrication. 
8.3.6. Photoinitiator Effects on Cell Viability 
The effects of Irgacure 2959 concentration on cell viability were assessed 
using the Live/Dead assay (calcein AM/ethidium homodimer; Invitrogen). Cells 
were exposed to Irgacure 2959 in 200 proof ethanol (100mg/mL) at final 
concentrations varying from 0.3 to 1.5% wtlvol for 5 min. The ratio of live cells 
(Calcein AM positive) to total cells (Calcein AM + Ethidium homodimer) was 
calculated for each condition using a fluorescent plate reader. 
8.3.7. Heterocellular Culture Effects on Hepatocyte Cytochrome P450 
Enzyme Function 
Heterocultures were seeded at a constant hepatocyte density (1000 
cells/cm2) and a fixed overall density of non-parenchymal cells (500 cell/cm2) as 
described in Table 3. Heterocultures were cultured at 37°C and 5% CO2 with 
eagles minimum essential medium MEM supplemented with 1 0% FBS and 1 % 
PS. As a fluorescent metabolic marker of cytochrome P450 activity, 7 -ethoxy-4-
trifluoromethylcoumarin (EFC) was added to the HEP G2 media to a final 
concentration of 100 IJM. EFC is common marker of hepatocyte function due to 
its ability to become fluorescent upon exposure to cytochrome P450 enzymes. 
Media from well plates with various cellular compositions was removed and 
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analyzed using a fluorescent plate reader at 24 and 72 h using filters set at 
(ex385/em502). 
Table 3: Ratios and Density of Heterocellular Culture Conditions 
Experimental Hepatocytes 3T3 Fibroblast HUVEC 10TYz 
Condition (cells cm2) (cells cm2) (cells cm 2) (cells cm 2) 
#1 1000 - - -
#2 1000 500 - -
#3 1000 - 400 100 
#4 Control - 500 
#5 Control 400 100 
8.3.8. Media Formulation Effects on Hepatocyte Cytochrome P450 Function 
The effects of media formulation on hepatocyte CYP450 function was 
analyzed to determine optimal media blends. HEP G2, HUVEC and10 T % cells 
were sub-cultured to 80-90% confluence prior to seeding as described in Section 
8.3.7. Tri-cultures of HEP G2, HUVECs and 10T1/2 were seeded in tissue culture 
polystyrene plates at 2,000,37,500 and 12,500 cells/cm2 respectively. Media 
formulations consisting of hepatocyte growth media (MEM), endothelial growth 
media (EGM-2) and blends of the two media (1/3 MEM: 2/3 EGM-2 and 2/3 MEM 
and 1/3 EGM-2) were supplemented with 100 IJM EFC to assay effects of media 
formulation on hepatocyte function. Negative controls (co-culture without 
hepatocytes) at each media condition were used to control for cellular 
autofluorescence and baseline EFC metabolism. Media was removed from the 
well plates and analyzed using a fluorescent plate reader at 24 h with filters set at 
(ex385/em502). 
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The transient effects of media formulations were analyzed to determine 
the ability to recover hepatocyte function after initial exposure to endothelial 
growth conditions that are known to form tubules. Tri-cultures were sub-cultured 
and seeded in well plates as previously described. All media formulations were 
supplemented with 100 IJM EFC to allow for monitoring of hepatocyte function. 
Tri-cultures were maintained in either hepatocyte media (MEM), endothelial 
growth media (EGM-2), or a blend of the two (1/2 MEM: 1/2 EGM-2) for 72 hr. 
The original media was then replaced with MEM and hepatocyte function 
recovery was assessed every 24 h for 72 h. A positive control where MEM media 
was maintained throughout the 6 day culture and a negative control where EGM-
2 media was maintained throughout were employed to determine a top and 
bottom limit for EFC metabolism. 
8.4. Results and Discussion 
8.4.1. PEGDA Hydrogels Fabricated using Mask Projection 
Photolithography and Softlithography 
Combination of sOftlithography and photolithography allows for microfluidic 
conduits to be rapidly fabricated over large length scales using soft lithographic 
techniques fOllowed by photolithographic fabrication of high fidelity hydrogel 
microstructures. (Figure 59 C) This multi modal fabrication scheme couples the 
advantages of a robust PDMS housing with the biomimetic capabilities of 
hydrogel biomaterials. A specific embodiment of these multimodal devices 
consist of softlithographically fabricated outer PDMS housing providing larger 
macroscale conduits, with an inlaid layer of softlithographically fabricated 
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hydrogel microchannels to provide efficient mass transport and interface with 
cells in between microchannels (Figure 59 C). Finally photolithographically 
patterned structures or biomolecule patterns within regions between microfluidic 
conduits can be used to mimic heterogeneous tissue microstructures. This is a 
highly biomimetic organization capable of mimicking complex tissue 
microenvironments. 
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Figure 58: Multilayer PEGDA Hydrogels Fabricated using Mask Projection 
PhotOlithography and Softlithography. Multilayer PEGDA hydrogels fabricated using Mask 
Projection Photolithography to fabricate a (A) heterogeneous tri-Iayer structure and (8) an array 
of pillars surrounded by a backfill solution. PEGDA pre-polymer solutions were doped with 10 IJm 
fluorescent microspheres to allow for structure visualization and to model cell encapsulation (C) 
Multimodal fabrications strategy combining a photolithographically fabricated pillars with 
encapsulated mouse hippocampus progenitor cells (MHP 36; red) with a softlithographically 
molded microchannel backfill solution containing human umbilical vein endothelial cells 
(HUVECs; green).(D) MPP feature size reduction demonstrates that mask features are reduced 
from 1.55x t011.55x between a 2.5x or 20x objective. 
The ability to photolithographically fabricate multilayer micron level 
structures requires precise alignment capabilities. The application of mask 
projection photolithography (MPP) provides a valuable tool pattern to rapidly 
photopolymerize PEG hydrogels with micron level precision over large areas. 
(Figure 59 A&B) Minimal modification of standard epifluorescent microscope 
146 
systems makes this technique an attractive option for a large number of 
researchers interested in patterning multilayer structures (see Figure 57). 
8.4.2. Photoinitiator Effects on Structure Formation and Cell Viability 
Other groups have reported the ability to photolithographically pattern 
poly(ethylene glycol) diacrylate (PEGDA) hydrogels with micron level precision in 
PDMS housings.14o However, the choice of hydrogel formation (MW = 575, and 
concentration> 20% wUvol) and photoinitiator concentration (>3% wU vol) is not 
conducive to high cell viability and does not provide a hydrogel system capable 
of robust cellular remodeling and tissue formation. We set out to determine 
photolithographic fabrication conditions that optimize structure fabrication while 
maintaining hydrogel formulations (6 kDa and 10% wUvol) and photoinitiator 
concentrations that preserve high cell viability. 
The type of solvent used to dissolve the photoinitiator was shown to play 
an active role in improving the efficiency of photoinitiator on structure fabrication. 
Ethanol is commonly used as a solvent for the photoinitiator Irgacure 2959 due to 
its high solubility limit. However, ethanol is passive in the photopolymerization 
process and only acts to improve photoinitiator solubility in the final highly 
aqueous hydrogel solution. Therefore, we sought to investigate the effects of a 
potentially non-passive solvating reagent on structure fabrication. N-
vinylpyrrolidone (NVP) contains a vinyl end-group similar to the terminal acrylate 
moiety on PEGDA. It was recently reported that the presence of hydrophobic 
acrylate micelles prior to network photopolymerization is one of the key 
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mechanisms in the crosslinking of PEGDA hydrogels. 3o Therefore we 
hypothesized that the addition of NVP as a solvent would have a stabilizing effect 
on micelle formation and therefore improve the efficiency of photopolymerization 
as indicated by the minimum concentration of photoinitiator needed to form a 
structure. 
It was observed that Irgacure 2959 in ethanol only formed structures at the 
highest concentrations tested (1.5% wtlvol; Table 4) while Irgacure 2959 
dissolved at the same concentration in NVP displayed structure formation at 
greater than half the effective concentration of Irgacure 2959 (0.6% wtlvol; Table 
4). This is an important finding because cell viability increased significantly when 
Irgacure 2959 concentration is decreased to within this range. (Figure 60) 
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Table 4: Effects of Photoinitiator Concentration and Solvent Type on Structure Formation 
Photoinitiator Concentration in Hydrogel (%wtlvol) 
+ Structure Formed 0.3 
X No Structure Formation 
Irgacure 
2959/Ethanol 
Irgacure 
2959/NVP 
~ 0.8 
:g 
5 0.6 
~ 
~ 0.4 1 
0.2 
o 
0.3 
X 
X 
0.9 1.5 
Irgac:ure 2959 (wt% ) 
0.6 0.9 1.2 
X X X 
3.0 
1.5 
Figure 59: Effects of Photoinitiator Concentration on Cell Viability. Irgacure 2959 in 200 
proof ethanol was shown to decrease cell viability in a dose dependent manor. 
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8.4.3. Heterocellular Culture on Hepatocyte Cytochrome P450 Function 
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Figure 60: Heteroculture Composition Effects on Hepatocyte Cytochrome p450 Function. 
P450 enzyme function as measured by EFC metabolism was assayed in hepatocytes alone, tri-
cultures containing hepatocytes, HUVECs and 10T % cells and a co-culture with hepatocytes and 
fibroblasts at 24 and 72 h of culture, 
The effect of heterocultures on hepatocyte EFC metabolism was assessed 
by analyzing CYP450 activity through EFC fluorescence . It was demonstrated 
that tri-cultures of hepatocytes with HUVECs and 1 OT ~ cells had the greatest 
effect on CYP450 activity with a greater than a twofold increase in EFC 
fluorescence over hepatocytes alone at 72 h of culture. Interestingly this amount 
was greater than the well characterize synergistic co-culture with NIH 3T3 
fibroblasts. (Figure 61) This happened despite the fact that total number of non-
parenchymal cells was held constant (see Table 3). Therefore this suggests that 
both the endothelial and 1 OT ~ cells are enhancing hepatocyte function via 
separate and potentially synergistic paths. The specific mechanism of 
enhancement is not clear and requires further study. 
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8.4.4. Media Formulation Effects on Hepatocyte Cytochrome P450 Function 
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Figure 61: Effect of Media Formulation on Hepatocyte Cytochrome P450 Function. Tri-
cultures were cultured in either MEM alone, EGM-2 alone, or blends of MEM and EGM-2 for 24 h. 
EFC fluorescence was measured using a plate reader to determine cytochrome P450 activity. 
One major limitation of complex heterocellular cultures is the wide 
variation in nutrient and signaling needs required to maintain cellular phenotype 
and function. Therefore much of our efforts have focused on determining culture 
conditions that drive microvascular formation from the pro-tubulogenic co-culture 
while still preserving hepatocyte functionality. It was shown that culturing of the 
tri-culture in endothelial growth media (EGM) media decreased CYP450 
metabolism as indicated by greater than a twofold decrease in EFC fluorescence. 
(Figure 62) Addition of hepatocyte recommended media (MEM) to EGM at final 
concentrations of 330/0 and 66% vol/vol improved EFC fluorescence in a dose 
dependent manor in proportion to the volume of MEM (Figure 62). 
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Figure 62: Transient Media Conditioning on Hepatocyte Cytochrome P450 Function. Tri-
cultures were cultured in either MEM, EGM-2, or a MEM:EGM-2 blend (red bar) for 72 h. Media 
formulations were switched to MEM and hepatocyte function was analyzed every 24 h for 72 h to 
determine ability to recover cytochrome P450 function. 
The ability to recover hepatocyte function after culturing in pro-tubulogenic 
media was assessed via a dynamic culture condition experiment. It was shown 
that by culturing tri-cultures in EGM media for 72 h, CYP450 function decreased 
by 90%. (Figure 63, Red bar) However, by switching to MEM media, the CYP450 
activity was fully recovered by 48 h and was greater than the MEM only control 
by 72 h. (Figure 63, Blue and orange bar) This is very interesting finding that 
suggests an initial period of tubule growth conditions to facilitate microvascular 
network formation can be followed by a period where hepatocyte function can be 
restored and improved due the increase in cell numbers. (Figure 63) This agrees 
with findings in the literature that show the addition of epidermal growth factor 
(EGF) and fibroblast growth factor (FGF), both components in EGM, to 
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hepatocyte cultures decreases CYP450 and albumin gene expression in favor of 
driving hepatocyte mitogenesis and clonal expansion. 18o,181 Confirming these 
findings our results, demonstrated that removal of the FGF and EGF from the 
media (Figure 63, EGM-MEM or Blend-MEM) restored hepatocyte function. 
8.5. Conclusions 
In conclusion we have demonstrated the ability to integrate multilayer soft 
and photolithographic fabrication techniques. In particular we have shown the 
ability to apply mask projection photolithography to the fabrication of multilayer 
PEG hydrogel structures. These technologies provide a valuable tool set to 
recapitulate complex heterogeneous cellular microenvironments within in vitro 
microdevices. Furthermore, we have shown the ability to adapt these 
technologies to fabrication conditions that are conducive to high cell viability and 
hydrogel compositions that allow for cell remodeling and tissue formation. These 
are important strides toward the merging of microfabrication technologies with 
highly bioactive PEG hydrogels. 
In addition we have begun to investigate heteroculture methods to 
combine parenchymal cell types with pro-vasculogenic co-cultures. In particular 
we have demonstrated a tri-culture formulation that enhances hepatocyte 
cytochrome P450 function greater than other co-cultures. This is a very 
interesting finding that demonstrates the potential of incorporating a single 
pluripotent cell source that can differentiate into multiple, functionally distinct 
phenotypes. We have also determined the optimal media formulation and 
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transient culture conditions that allows for initial tubule growth while still 
maintaining the ability to recover hepatocyte function. This finding highlights the 
plasticity of hepatocytes and emphasizes the need to provide distinct and 
dynamic signaling regimes at different times in tissue development. Together 
these findings lay the groundwork to fabricate and culture a BAL with cellular 
components that have highly biomimetic structure function relationships. 
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9. Chapter 9: Strategic Directions in Microvascular 
Tissue Engineering 
1. Engineering interfaces 
Developing fabrication technologies to build multilayer devices is an important 
step towards recapitulating tissue microstructures. However, beyond developing 
multiple layers it is important to carefully design and integrate the interfaces 
between layers. Interfacial engineering in microfabricated hydrogel systems 
should focus on (1) the interface between the flowing solution in the 
microchannel and the hydrogel microchannel wall (sol-gel interface) and (2) the 
interface between heterogeneous hydrogel structures (gel-gel interface). 
Furthermore, interface engineering should account for both biochemical design 
motifs and control over the physical microenvironment. 
In the case of the perfused microfluidic channel and the hydrogel matrix 
channel wall there is sol-gel interface. One design choice that needs to be 
considered is developing flow regimes that are diffusion limited (Peclet Number 
» channel length/channel height) but have acceptable microvascular shear 
stress values (5-15 dyne/cm2) for cells that are present at the interface. This 
optimization becomes non-convergent if you also constrain channel diameter and 
solution viscosity. Therefore it is important to consider whether the application of 
the system places emphasis on optimal mass transport, physiological shear, or 
biomimetic channel geometries. 
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Another sol-gel design consideration focuses on the functionalization of 
the interface for controlled anastomosis or encapsulated cell interaction with the 
solution. Tools to address this challenge include patterning of biochemical cell-
cell proteins, such as Ephrin A1, or cell-matrix ligands, such as RGDS or IKVAV 
peptides, that control where cells in the hydrogel bulk can interact with the 
channel wall (see Section 4.2 and 4.3). Another method that can be used in 
conjunction with biochemical functionalization is developing structural 
modifications to the interface that can control anastomosis. Some possible 
designs include microvilli like protrusions into or out of the channel wall or non-
degradable pillars at the interface that can spatially confine cellular interaction 
with the flowing solution. Combination of biochemical and physical interface 
design provides a mechanism to better control integration across lengths scales 
and fabricated structure-cellular element assimilation. 
When engineering the gel-gel tissue structure interface in vitro it is unclear 
whether it is advantageous to pattern heterogeneous tissue mimetic structures or 
to homogenously mix multiple cell types know to be present in the native tissue 
and allow for self-assembly to drive tissue formation. It is likely that a 
combination of fabricated structures guidance followed by self-assembly will be 
required to generate tissue mimetic structure-functional relationships in vitro. 
Therefore gel-gel interface design should employ both biochemical and physical 
designs in integrate cellular self-assembly with fabricated structures. Some 
potential deSign ideas could involve patterned pro-migratory regions between 
interface with decreased matrix density and increases adhesive or pro-mitogenic 
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signals. Other simpler designs could be the encapsulation or loading of 
biochemical signals within structures as a tool to control signaling gradients and 
drive cell migration to and from structures. Also fabricated structures acting as 
signaling or nutrient gradient sinks or sources provides another order of control 
over tissue pattern formation beyond initial fabricated structures. 
2. Freeform 3D fabrication methods 
With the exception of photocleavable PEG derivative work reported by 
Kloxin et a/123, (see Figure 24) most fabrication methods reported in the literature 
are restricted to planar designs. Even the photocleavable technologies are 
limited by long writing or exposure times with a costly and uncommon two-photon 
confocal microscope system. Other softlithographic designs may be amenable to 
scaling in the third dimension, via layer-by-Iayer approaches, however robust 
technologies to microfabricate hydrogels using 3D free form fabrication have not 
been reported to the best of our knowledge. 
The lack of progress in this area is likely due to a combination of material 
property limitations and means to convey spatial information to the material. 
Fabrication of high aspect ratio hydrogel structures that do not collapse or deform 
under their own weight is difficult due to the relatively low elastic modulus of the 
highly aqueous materials. Rapid prototyping techniques have applied removable 
filler substrates to support structures during fabrication followed by steps to 
dissolve away the support structures. This outside-in approach is a potential 
option for 3D free form fabrication as long as the filling support structure can be 
removed under conditions that do not damage the hydrogel and more importantly 
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maintain cell viability. A similar but converse inside-out approach could involve 
initially building dissolvable structures and backfilling around the structures with 
the final hydrogel material. This would be followed by dissolving the interior 
sacrificial structures in a "lost wax" or sacrificial poragen process. This technique, 
like the outside-in approach, must apply highly cell and hydrogel compatible 
dissolution processes. 
One potential materials fabricating scheme could apply an enzymatically 
degradable material as either the filling support structure or the sacrificial 
poragen. This would allow for aqueous and cell compatible degradation 
conditions. However, this approach requires that the support or poragen 
dissolution enzyme does not have cross reactivity with the final hydrogel scaffold. 
Progress in 3D free-form fabrication technologies will likely have broad 
implications to all materials fabrication sectors and will improve the state of the 
art for developing 3D microstructures. 
3. Multipotent cellular elements and clinically viable cell sources 
Incorporation of multiple terminally differentiated cell types into tissue 
engineered constructs is one approach to recapitulate complex tissues in vitro. 
However, this approach is plagued by the need to provide unique signals and 
culture environments for each cell type. This is difficult to not possible if the cells 
of interest are not plastic enough to recover function upon termination of 
orthogonal culture conditions. Furthermore, this approach is not well suited to the 
clinically preferred autologous cell source due to the need to harvest from 
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multiple tissues, the lack of donor site availability and unacceptable damage to 
the donor site. 
An interesting and intense area of research to address this limitation is the 
use of a single multipotent cell type to drive formation of both parenchymal and 
functional cellular elements. This approach would closely mimic native tissue 
development and would allow for harvesting of cells from a single source tissue. 
Furthermore the use of a Single, multipotent cell type improves the feasibility of 
cell cryostorage banks as a long term cell source. It is important that continued 
progress in stem cell and developmental biology research result in 
multidisciplinary collaborations that drive improvements in knowledge and cell 
sources available to tissue engineers. 
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11. Chapter 11: Appendices 
11.1. Bioconjugate Synthesis Characterization 
11.1.1. 
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Figure 63: Gel Permeation Chromatography (GPC) of Laysan-PEG-NHS conjugation to PQ 
peptide. (A) No dialysis purification and (8) one dialysis purification step (C) two-stage dialysis 
purification and (0) Christy Franco batch with no dialysis. Conjugation batched (8-0) were able to 
be replica molded to 50 ~m photoresist masters. 
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Figure 64: Gel Protein Chromatography (GPC) of Laysan-PEG-NHS conjugation to RGDS. 
(White Trace) Acryoyl-PEG-NHS from Laysan Bio. Inc. show a peak for PEG-NHS eluting at 7.25 
min. (Red Trace) Conjugation of RGDS to PEG-NHS show a the shift in the PEG -RGDS peak to 
elution at 6 min. 
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11.1.2. Matrix Assisted Laser Desorption/Ionization Time of Flight 
Mass Spectroscopy (MALDI TOF) 
~104 
11 2 . 5 
2 . 0 
1 . 5 
1 . 0 
118 5 
Figure 65: Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectroscopy 
(MALOI TOF) of solid state peptide synthesis prod uct for the collagen derived PQ peptide . 
Peak at 1185 is the target molecular weight for the peptide. 
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11.2. Raw Diffusion Data For Studies Reported in Chapter 6 
50/0 PEGDA Toluidine Blue Diffusion Profiles 
t=Om t= 100 m 
Figure 66: Representative Images of 50/0 PEGDA Toluidine Blue Diffusion Prof1les 
10% PEGDA Toluidine Blue Diffusion Profiles 
t=Om t= 10m = 100m 
=200m 
Figure 67: Representative Images of 10% PEGDA Toluidine Blue Diffusion Profiles 
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20% PEGDA Toluidine Blue Diffusion Profiles 
...-
t=Om / t= 10m t= 100m 
t=200 m t= 300 m 
Figure 68: Representative Images of 200/0 PEGDA Toluidine Blue Diffusion Profiles 
3kDa Dextran Fluorescein Diffusion Profiles 
Figure 69: Representative Images of 10% PEGDA 3kDa Dextran Fluorescein Diffusion Profiles 
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10kDa Dextran Fluorescein Diffusion Profiles 
Figure 70: Representative Images of 10% PEGDA 10kDa Dextran Fluorescein Diffusion Profiles 
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